0001213900-20-005061.txt : 20200228 0001213900-20-005061.hdr.sgml : 20200228 20200228172013 ACCESSION NUMBER: 0001213900-20-005061 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200228 DATE AS OF CHANGE: 20200228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tengjun Biotechnology Corp. CENTRAL INDEX KEY: 0001499785 STANDARD INDUSTRIAL CLASSIFICATION: RADIO BROADCASTING STATIONS [4832] IRS NUMBER: 273042462 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-169397 FILM NUMBER: 20672358 BUSINESS ADDRESS: STREET 1: FL 4 AIRPORT INDUSTRIAL PARK BIZ CENTER STREET 2: NO.35 CHANGJIANG SOUTH ROAD, NEW DIST. CITY: WUXI STATE: F4 ZIP: 214028 BUSINESS PHONE: 8613909840703 MAIL ADDRESS: STREET 1: FL 4 AIRPORT INDUSTRIAL PARK BIZ CENTER STREET 2: NO.35 CHANGJIANG SOUTH ROAD, NEW DIST. CITY: WUXI STATE: F4 ZIP: 214028 FORMER COMPANY: FORMER CONFORMED NAME: China Herb Group Holdings Corp DATE OF NAME CHANGE: 20120717 FORMER COMPANY: FORMER CONFORMED NAME: Island Radio, Inc. DATE OF NAME CHANGE: 20100823 10-K 1 f10k2019_tengjunbiotech.htm ANNUAL REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2019

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 333-169397

Tengjun Biotechnology Corp.

(Exact name of registrant as specified in its charter)

Nevada		333-169397		27-3042462
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

527 Siltstone Place, Cary, NC 27519

(Address of principal executive offices and zip code)

(919) 869-0279

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Securities registered pursuant to section 12(g) of the Act:

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. YES ☐ NO ☒

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ☒ NO ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☒ NO ☐

The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant, as of June 28, 2019, was $22,670,675 (based upon the closing price of the registrant’s common stock of $1.25 per share as reported by the OTC Bulletin Board for the last trading date prior to this date).

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 43,216,580 shares of common stock, as of February 28, 2020.

TABLE OF CONTENTS

Item			Page
PART I
	Item 1	Business	1
	Item 1A	Risk Factors	4
	Item 1B	Unresolved Staff Comments	4
	Item 2	Properties	4
	Item 3	Legal Proceedings	4
	Item 4	Mine Safety Disclosure	4

PART II
	Item 5	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	5
	Item 6	Selected Financial Data	5
	Item 7	Management’s Discussion and Analysis of Financial Condition and Results of Operations	5
	Item 7A	Quantitative and Qualitative Disclosures About Market Risk	8
	Item 8	Financial Statements and Supplementary Data	8
	Item 9	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	8
	Item 9A	Controls and Procedures	9
	Item 9B	Other Information	10

PART III
	Item 10	Directors, Executive Officers and Corporate Governance	11
	Item 11	Executive Compensation	13
	Item 12	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	13
	Item 13	Certain Relationships and Related Transactions and Director Independence	14
	Item 14	Principal Accountant Fees and Services	14

PART IV
	Item 15	Exhibits, Financial Statement Schedules	15
Signatures			16

PART I

FORWARD LOOKING STATEMENTS

There are statements in this report that are not historical facts. These “forward-looking statements” can be identified by use of terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions. You should be aware that these forward-looking statements are subject to risks and uncertainties that are beyond our control. For a discussion of these risks, you should read this entire report carefully, especially the risks discussed under the section entitled “Risk Factors.” Although management believes that the assumptions underlying the forward looking statements included in this report are reasonable, they do not guarantee our future performance, and actual results could differ from those contemplated by these forward looking statements. The assumptions used for purposes of the forward-looking statements specified in the following information represent estimates of future events and are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances. As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives require the exercise of judgment. To the extent that the assumed events do not occur, the outcome may vary substantially from anticipated or projected results, and, accordingly, no opinion is expressed on the achievability of those forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results and events contemplated by the forward-looking statements contained in this report will in fact transpire. You are cautioned to not place undue reliance on these forward-looking statements, which speak only as of their dates. We do not undertake any obligation to update or revise any forward-looking statements.

As used in this Annual Report, unless otherwise noted, references to the “Company”, “we”, “our” or “us” means Tengjun Biotechnology Corp. unless the context clearly requires otherwise.

Item 1. Business

Overview of Our Business

Recent History

We were incorporated on June 28, 2010 in the State of Nevada under the name “Island Radio, Inc.” and changed our name to “China Herb Group Holdings Corporation” effective July 17, 2012. On December 9, 2019, we changed our name to Tengjun Biotechnology Corp.

On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the “Sellers”), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the “Purchasers”), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the “Change in Control”). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company.

Our original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, we changed our business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with our professional and business advisors in the United States and the People’s Republic of China (“China or the “PRC”), our management decided during the third quarter of 2014 that this would no longer be our plan of operations. No agreements had been entered into by us with any party in connection with such plan of operations.

Business Model

We currently have no business operations. We currently intend to evaluate new industry, geographic and market opportunities. Our entry into a new business may take the form of acquiring a business or being acquired by an existing business or, least likely, developing a business organically. Any such efforts may require significant capital, which we currently lack. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, we will have the financial and other resources available to take advantage of such opportunity, since we have extremely limited liquidity.

We will look for potential target companies in a broad range of industries and we may engage in a business combination with any type of business. We intend to focus on target companies that are located or operate exclusively or primarily in China, although, under certain circumstances, we would consider a business combination with a company located or operating in a different country. The circumstances under which we would consider a business combination with a company located or operating in a country other than China would be primarily those situations where we are unable to locate a suitable business combination candidate in China or in response to a change in interest on the part of U.S. investors in investing in China such that such a business combination would no longer be considered advantageous to us.

The analysis of target companies and the business opportunities they may present to us will be undertaken by or under the supervision of the Company’s officer and director, Qiuping Lu. As of this date, we have not entered into any definitive agreement with any target company or any other party. No assurance can be given that we will consummate a transaction with any target company. We have unrestricted flexibility in seeking and analyzing target companies, and structuring and negotiating a business combination. In our efforts to analyze potential target companies, we consider numerous factors, including the following:

●

Potential for growth, indicated by new technology, existing brand name recognition, market penetration, anticipated market expansion and/or new products;

●

Competitive position as compared to other businesses of similar size and experience within the industry segment as well as within the industry as a whole;

●

Strength and diversity of the target company’s management, either in place or scheduled for recruitment;

●

Capital requirements and anticipated availability of required funds, to be provided by the Company, from operations of the target company, through the sale of additional securities, through joint ventures or similar arrangements or from other sources;

●

The cost of participation by the Company as compared to the perceived tangible and intangible values and potentials;

●

The extent to which the target company’s business opportunity can be advanced by means of the business combination;

●

The accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items; and

●

Other relevant factors based on industry, geopolitical, market and other considerations.

In applying the foregoing criteria, no one of which will be controlling, we will attempt to analyze all facts and circumstances and make a determination based upon reasonable investigative measures, due diligence and available data. Potentially available business opportunities may occur in many different industries, and target companies may be at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. However, due to our limited capital available for investigation and due diligence, we may not discover or adequately evaluate adverse facts about a target company. In addition, we will be competing against other entities that possess greater financial, technical and managerial capabilities for identifying and completing business combinations.

In evaluating a target company and potential business combination, we will conduct as extensive a due diligence review of potential target companies as is reasonably possible given the relative lack of information which may be available regarding private companies, our limited personnel and financial resources and the inexperience of our management with respect to such endeavors. We expect that our due diligence will encompass, among other things, meetings with the potential target company’s incumbent management and inspection of its facilities, as necessary, as well as a review of financial and other information, and agreements, to the extent they are made available to us.

This due diligence review will be conducted by our management and/or unaffiliated third parties, including professionals, who we may engage. Despite such efforts, our limited funds and the lack of our having full-time management will likely make it impracticable to conduct a complete and exhaustive investigation and analysis of a target company before we consummate a business combination. Management decisions, therefore, will likely be made without detailed feasibility studies, independent analysis, market surveys and the like which, if we had more funds and personnel available to us, would be suitable in analyzing a target company. We will be particularly dependent in making decisions upon information provided by the promoters, owners, sponsors, directors and officers or other affiliates or agents of the target company, and we may not be able to ascertain the accuracy or completeness of all such information that is provided to us. We will also face competitive pressures in identifying target companies and negotiating and consummating a business combination.

Form of Business Combination

The manner in which we structure a business combination will depend upon numerous factors, including the nature of the opportunity, the respective needs and desires of the Company and the target company, the relative negotiating strength of the Company and the target company, and certain legal and regulatory considerations. Typical forms of business combinations include statutory mergers, stock purchases, share exchanges and asset purchase transactions. However, it is likely that, in engaging in a business combination with a target company, we will issue shares of our Common Stock or other securities to the stockholders of the target company as sole or partial consideration.

Although the terms of any business combination cannot be predicted, it should be noted that in certain circumstances the criteria for determining whether or not an acquisition is a so-called “tax free” reorganization under Section 368(a)(1) of the Internal Revenue Code of 1986, as amended (the “Code”) depends upon whether the owners of the acquired business (the target company) own 80% or more of the voting stock of the surviving entity at the conclusion of the transaction. If a business combination were structured to take advantage of these provisions rather than other “tax free” provisions provided under the Code, our then-existing stockholders in the aggregate would in such circumstances retain 20% or less of the total issued and outstanding shares of the Company upon the consummation of the business combination. Depending upon the relative negotiating strength of the parties, our then-existing stockholders may retain substantially less than 20% of the total issued and outstanding shares of the Company upon the consummation of the business combination. It is likely that as a result of a business combination, however it is structure, our then-existing stockholders would incur substantial additional dilution in their percentage ownership of the Company compared to their ownership percentage prior to the business combination.

Depending upon the way the business combination is structured, it may be accomplished upon the sole determination of our then-serving directors without any vote or approval by our stockholders. However, in the case of a statutory merger or consolidation directly involving the Company, it will likely be necessary under Delaware law to call a stockholders’ meeting and obtain the approval of the holders of a majority of our voting securities outstanding on the record date. Should it be necessary to obtain such stockholder approval, there could be a delay and additional expense involved in approving the proposed business combination. Additionally, such a structure will also likely give rise to certain appraisal rights to dissenting stockholders under Delaware law. For these and other reasons, our management will likely seek to structure any business combination so as not to require stockholder approval or trigger appraisal rights in favor of dissenting stockholders.

The time and costs required to identify, select and conduct due diligence on a target company and to structure, negotiate, document and consummate a business combination cannot presently be ascertained with any degree of certainty. However, such efforts will require substantial management time and attention and substantial cost for accountants, attorneys and others. Any costs incurred with respect to the identification and evaluation of a target company and potential business combination that is not ultimately completed will result in unrecoverable expenses to us. Finally, there can be no assurance that any business combination which is consummated will be on terms that are favorable to us and our stockholders.

Competition

We are in a highly competitive market for a relatively small number of business opportunities which could reduce the likelihood of consummating a successful business combination. We are, and will continue to be, a minor participant in the business of seeking business combinations with target companies. A large number of established and well-financed entities, including small public companies, private equity firms, hedge funds and venture capital firms, are active in mergers and acquisitions of companies that may be suitable target companies for us. Nearly all of these entities with which we would compete for target companies have significantly greater financial resources, technical expertise and managerial capabilities than we do. Additionally, we will be competing with other companies who have a similar business model to ours, including special purpose acquisition companies (SPACs) and other strategic acquirers. Consequently, we will face stiff competition and may be at a competitive disadvantage in identifying possible business opportunities and successfully completing a business combination with a target company. These competitive factors may reduce the likelihood of our identifying and consummating a successful business combination on favorable terms or at all.

Certain Regulatory Matters

Based on the current and proposed business activities described above, the Company is a “blank check” company. The Securities and Exchange Commission (the “SEC”) defines a blank check company as “any development stage company that is issuing a penny stock, within the meaning of Section 3 (a)(51) of the Securities Exchange Act of 1934 (the {“Exchange Act”), and that has no specific business plan or purpose, or has indicated that its business plan is to merge with an unidentified company or companies.”

Pursuant to Rule 12b-2 under the Exchange Act, the Company is also a “shell company” because it has no or nominal assets (other than cash) and no or nominal operations. Many states have enacted statutes, rules and regulations limiting the sale of securities of “blank check” companies in their respective jurisdictions.

We intend to comply with the periodic reporting requirements of the Exchange Act for so long as we are subject to those requirements.

Our office is located at 527 Siltstone Place, Cary, NC 27519, and our telephone number is (919) 869-0279.

Employees

As of December 31, 2019, we had no employees. All functions, including development, strategy, negotiations and administration, are currently being provided by our director and officer, Qiuping Lu. Ms. Lu is engaged in outside business activities and anticipates that she will devote very limited time to our business until a successful business opportunity has been identified. We currently expect no significant changes in the number of our employees other than such changes, if any, incidental to a business combination.

Item 1A. Risk Factors

As a “smaller reporting company”, as defined in Rule 12b-2 under the Exchange Act, we are not required to provide the information required by this Item.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

The Company does not own any office space or equipment. The Company uses office space of a related party, free of rent, which is considered immaterial.

Item 3. Legal Proceedings

There are presently no material pending legal proceedings to which the Company is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

Item 4. Mine Safety Disclosure

Not applicable.

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Since July 17, 2014, our common stock has been quoted on the OTCQB under the trading symbol “CHGH”. On December 9, 2019, our trading symbol was changed to “TJBH”. For the periods indicated, the following table sets forth the high and low bid prices per share of common stock. The below prices represent inter-dealer quotations without retail markup, markdown, or commission and may not necessarily represent actual transactions:

	Fiscal 2019				Fiscal 2018
	High		Low		High		Low
First Quarter ended March 31	$	3.25	$	2.50	$	3.90	$	3.90
Second Quarter ended June 30	$	2.86	$	1.25	$	3.90	$	0.75
Third Quarter ended September 30	$	1.90	$	1.00	$	2.50	$	0.75
Fourth Quarter ended December 31	$	12.50	$	1.75	$	2.50	$	2.50

As of February 28, 2020, there were 88 registered holders of our common stock.

Dividend Policy

We have never declared or paid cash dividends. We currently intend to retain all future earnings for the operation of our business and do not anticipate paying cash dividends on the common stock in the foreseeable future. Any payment of cash dividends in the future will be at the discretion of our Board of Directors and will depend upon our results of operations, earnings, capital requirements, contractual restrictions and other factors deemed relevant by our director.

Securities Authorized for Issuance under Equity Compensation Plans

As of February 28, 2020, we have not adopted an equity compensation plan and have not granted any stock options.

Recent Sales of Unregistered Securities

On August 28, 2019, the Company sold 5,000,000 shares of common stock at a purchase price of $0.001 per share to an investor pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $5,000.

On January 22, 2020, the Company sold 80,040 shares of common stock at a purchase price of $0.03 per share to seven investors pursuant to stock purchase agreements. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $2,405.

Issuer Purchases of Equity Securities

We have not repurchased any of our equity securities during the period covered by this report.

Item 6. Selected Financial Data

Not applicable.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our results of operations and cash flows for the years ended December 31, 2019 and 2018 and financial condition as of December 31, 2019 should be read in conjunction with our financial statements and the related notes included elsewhere in this report.

We have no business operations and are not currently generating any revenue. Our independent registered public accounting firm has issued a going concern opinion. This means that our auditors believe there is substantial doubt that we can continue as an on-going business for the next 12 months. We do not anticipate generating revenue until we engage in a merger or other business combination with an operating business. Accordingly, we must raise additional cash from sources other than operations to meet our expenses.

Plan of Operations

We currently have no business operations. We currently intend to evaluate new industry, geographic and market opportunities. Our entry into a new business may take the form of acquiring a business, being acquired by an existing business or, least likely, developing a business organically. Any such efforts may require significant capital, which we currently lack. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, we will have the financial and other resources available to take advantage of such opportunity, since we have extremely limited liquidity.

We will look for potential target companies in a broad range of industries and we may engage in a business combination with any type of business. We intend to focus on target companies that are located or operate exclusively or primarily in China, although, under certain circumstances, we would consider a business combination with a company located or operating in a different country. The circumstances under which we would consider a business combination with a company located or operating in a country other than China would be primarily those situations where we are unable to locate a suitable business combination candidate in the China or in response to a change in interest on the part of U.S. investors in investing in China such that such a business combination would no longer be considered advantageous to us.

Our principal strategic objective for the next 12 months and beyond will be to identify and consummate a business combination with a target company. There are no agreements with any such target company and there can be no assurance that we will engage in a business combination within the next 12 months or at any time in the future.

During at least the next 12 months, unless we complete a business combination sooner, we anticipate incurring costs primarily related to:

	●	preparing and filing Exchange Act reports;

	●	identifying, investigating and conducting due diligence on target companies; and

	●	negotiating, structuring, documenting and consummating a business combination.

We believe that we will be able to meet these costs through cash on hand and additional amounts, as may be necessary, to be loaned by or invested in us by our stockholders, management and/or others. Currently, however, our ability to continue as a going concern is dependent upon our ability to generate future profitable operations and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they come due. Our ability to continue as a going concern is also dependent on our ability to find a suitable target company and enter into a business combination. Management’s plan includes obtaining additional funds through a combination of sales of our equity securities before, contemporaneously with, or following, the consummation of a business combination; and borrowings, although we do not believe that we will be eligible to borrow funds from a bank until at least a business combination is consummated. However, here is no assurance that any additional funding will be available on terms that are favorable to us or at all.

We currently rely on loans from our director and officer, Qiuping Lu, to meet our expenses. There is no guarantee that Ms. Lu will continue to lend us funds to meet our expenses in the future. Currently, we do not have any other arrangements for financing. We have no assurance that future financing will be available to us on acceptable terms, or at all. If financing is not available to us on satisfactory terms or at all, we may be unable to develop operations or meet our expenses. Additionally, any equity financing in which we might engage would result in dilution to our existing shareholders.

Results of Operations

Year Ended December 31, 2019 Compared to Year Ended December 31, 2018

Revenues. During the years ended December 31, 2019 and 2018, we did not generate any revenues.

Operating Expenses. For the year ended December 31, 2019, total operating expenses amounted to $39,493 as compared to $29,898 for the year ended December 31, 2018, an increase of $9,595 or 32.1%. Since inception, our operating expenses primarily consisted of listing fees and expenses related to complying with our ongoing SEC reporting requirements, which have mainly consisted of accounting fees, transfer agent fees, and filing fees.

Other expenses. During the years ended December 31, 2019 and 2018, we recorded $20,372 and $17,908, respectively, in imputed interest expenses related to advances outstanding to related parties. These imputed interests were recorded in our financial statements under additional paid-in capital.

Net Loss. During the years ended December 31, 2019 and 2018, we had a net loss of $59,865 and $47,806, respectively.

Liquidity and Capital Resources

As of December 31, 2019, we did not have any cash, while, we had liabilities of $283,939, and had a working capital deficit of $279,640. We expect to incur continued losses during 2020, possibly even longer.

For the years ended December 31, 2019 and 2018, net cash used in operating activities amounted to $39,792 and $30,440, respectively. We expect to require working capital of approximately $50,000 over the next 12 months to meet our financial obligations.

For the years ended December 31, 2019 and 2018, net cash provided by financing activities amounted to $39,792 and $30,440, respectively. For the year ended December 31, 2019, we received proceeds from loans from officer of $39,792, received proceeds from sale of common stock of $5,000, and made repayment for loans from officer of $5,000. For the year ended December 31, 2018, we received proceeds from loans from officer of $33,377 for working capital purposes and made refund of $2,937 for advance for future common stock subscriptions.

We have not generated any revenues from operations to date. It is not likely that we will generate any revenue until at least a business combination has been consummated. Even following a business combination, there is no guarantee that any revenues will be generated or that any revenues will be sufficient to meet our expenses. We may consider a business combination with a target company which itself has recently commenced operations, is a developing company in need of additional funds for expansion into new products or markets, is seeking to develop one or more new products or services, or is an established business which may be experiencing financial or operating difficulties and is in need of additional capital.

Moreover, any target business that is selected may be financially unstable or in the early stages of development or growth, including businesses without established records of sales or earnings. In that event, we will be subject to numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. In addition, we may effect a business combination with a target company in an industry characterized by a high level of risk, and, although our management will endeavor to evaluate the risks inherent in a particular target company, there can be no assurance that we will properly ascertain or assess all significant risks.

The foregoing considerations raise substantial doubt about our ability to continue as a going concern. We are currently planning on devoting the vast majority of our efforts to identifying, investigating and conducting due diligence on target companies; and negotiating, structuring, documenting and consummating a business combination. Our long-term ability to continue as a going concern is dependent upon our ability to develop additional sources of capital, complete a business combination and, thereafter, achieve profitable operations.

During the fiscal years ended December 31, 2019 and 2018, Ms. Lu, the director and officer of us, advanced an aggregate $39,792 and $33,377, respectively, to us to pay some of our expenses and for working capital purposes, and we made repayments to Ms. Lu of $5,000 in 2019. These advances in the aggregate amounts of $272,814 and $238,022, respectively, at December 31, 2019 and 2018, are payable on demand and are reflected as related party loans on the accompanying balance sheets.

Imputed interest of $20,372 and $17,908 was recorded for the years ended December 31, 2019 and 2018, respectively, and the imputed interest was recorded as interest expense and an increase in additional paid-in capital, respectively.

Going Concern Consideration

Our independent auditors included an explanatory paragraph in their report on the accompanying financial statements regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that lead to this disclosure by our independent auditors.

Contractual Obligations

As of December 31, 2019, we had no contractual obligations.

Off –Balance Sheet Operations

As of December 31, 2019, we had no off-balance sheet activities or operations.

Critical Accounting Policies

Please refer to Note 2 - Summary of Significant Accounting Policies of our financial statements accompanying this report.

Recently Issued Accounting Pronouncement

For details of applicable new accounting standards, please, refer to Recent Accounting Pronouncements in Note 2 of our financial statements accompanying this report.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 8. Financial Statements and Supplementary Data

See pages F-1 through F-11.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures

Under the supervision and with the participation of our officers and directors, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act as of a date ("Evaluation Date") within ninety (90) days prior to the filing of our Annual Report for the year ended December 31, 2019 on Form 10-K with the SEC.

Based upon that evaluation, our management has concluded that, as of December 31, 2019, our disclosure controls and procedures were not effective in timely alerting management to the material information relating to us required to be included in our periodic filings with the SEC.

Our officers and directors have concluded that our disclosure controls and procedures had the following material weaknesses:

●

We were unable to maintain any segregation of duties within our financial operations due to our reliance on limited personnel in the finance function. While this control deficiency did not result in any audit adjustments to our 2019 interim or annual financial statements, it could have resulted in a material misstatement that might have been prevented or detected by a segregation of duties;

●

We lack sufficient resources to perform the internal audit function and do not have an Audit Committee;

●

We do not have an independent Board of Directors, nor do we have a board member designated as an independent financial expert. The Board of Directors is comprised of one (1) member who is also our only executive officer. As a result, there is a lack of independent oversight of the management team, lack of independent review of our operating and financial results, and lack of independent review of disclosures made by us;

●

The Company has no formal control process related to the identification and approval of related party transactions; and

●

Documentation of all proper accounting procedures is not yet complete.

These weaknesses have existed since our inception on June 28, 2010 and, as of December 31, 2019, have not been remedied. To the extent reasonably possible given our limited financial and personnel resources, we intend to take measures to cure the aforementioned material weaknesses, including, but not limited to, the following:

●

Consider the engagement of consultants to assist in ensuring that accounting policies and procedures are consistent across the organization and that we have adequate control over financial statement disclosures;

●

Hire additional qualified financial personnel, including a Chief Financial Officer, on a full-time basis;

●

Expand our board of directors to include additional independent individuals willing to perform directorial functions; and

●

Increase our workforce in preparation for commencing revenue producing operations.

Since the recited remedial actions will require that we hire or engage additional personnel, these material weaknesses may not be overcome in the near-term due to our limited financial resources. Until such remedial actions can be realized, we will continue to rely on the limited advice of outside professionals and consultants.

Internal Control over Financial Reporting

(a)

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our officers assessed the effectiveness of our internal control over financial reporting as of December 31, 2019. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in 2013 Internal Control-Integrated Framework. Based on that assessment under such criteria, management concluded that our internal controls over financial reporting were not effective as of December 31, 2019 due to control deficiencies that constituted material weaknesses.

Management has identified a lack of sufficient personnel in the accounting function, due to our limited resources, with appropriate skills, training and experience to perform the review processes to ensure the complete and proper application of generally accepted accounting principles.

We are in the process of developing and implementing remediation plans to address our material weaknesses in our internal controls.

Management has identified specific remedial actions to address the material weaknesses described above:

●

Improve the effectiveness of the accounting group by augmenting our existing resources with additional consultants or employees to improve segregation procedures and to assist in the analysis and recording of complex accounting transactions and preparation of tax disclosures. We plan to mitigate the segregation of duties issue by hiring additional personnel in the accounting department once we have achieved positive cash flow from operations and/or have raised significant additional working capital; and

●

Improve segregation procedures by strengthening cross approval of various functions including cash disbursements and quarterly internal audit procedures where appropriate.

Inherent Limitations on Effectiveness of Controls

Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

(a)

Attestation Report of the Registered Public Accounting Firm

This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by our independent registered public accounting firm pursuant to rules of the SEC that permit us to provide only management's report in this Annual Report. We were not required to have, nor have we, engaged our independent registered public accounting firm to perform an audit of internal control over financial reporting pursuant to the rules of the SEC that permit us to provide only management’s report in this Annual Report.

(b)

Changes in Controls and Procedures

There were no significant changes made in our internal controls over financial reporting during the year ended December 31, 2019 that have materially affected or are reasonably likely to materially affect these controls. Thus, no corrective actions with regard to significant deficiencies or material weaknesses were necessary.

Item 9B. Other Information

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

As of February 28, 2020, our executive officers and directors were as follows:

Name	Age	Position

Qiuping Lu	48	President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director

Xianchang Ma (*)	44	Vice President and Director

Suzhen Zhang (*)	65	Director

Huaping Lu (*)	52	Director

(*) Appointed on December 10, 2019

Qiuping Lu, age 48, has served as the Company’s President, Chief Executive Officer, Chief Financial Officer and a director since June 27, 2012. Ms. Lu was the Accounting Director of Jiangsu Jiu Jiu Accounting Firm from 1998 to 2003 and was the Accounting Director of Changzhou Nonferrous Metal Factory from 1991 to 1998. Ms. Lu graduated from the Accounting Major of Changzhou Industrial Institute in 1991.

Xianchang Ma, age 44, established a company named Jinan Tengiun Biological Technology Co., Ltd in 2014. Over the years, Mr. Ma has devoted himself to enterprise management and has abundant corporate management experience. In 2015, he returned to the county of Jinxiang and founded the company of Jinxiang Kanglong Water Purification Equipment Co., Ltd. On November 22, 2011, he established the company named Jinan Kanglong Environmental Protection Technology Co., Ltd; From 2009 to 2011, Mr. Ma served as Marketing and Sales Director of Shijiazhuang Shikang Fuchang Technology Co., Ltd. From 2007 to 2009, he was the sales clerk of Shenzhen Rongge Company. And from 1994 to 2007, Mr. Ma was self-employed.

Suzhen Zhang, age 65, has served as the executive manager of Tengjun Biotechnology Corp. since 2015. From 2004 to 2014, Ms. Zhang was the chairman and General Manager of Nanjing Zhuoren Communication Co., Ltd. From 1997 to 2002, she was the Director of Jiangyan Telecommunication Bureau. In 1996, Ms. Suzhen Zhang served as Director of Taizhou Telecommunication Bureau. In 1989, Ms. Zhang was chief of the Unit of Taizhou Telecommunication Bureau. In the year of 1971, Ms. Zhang started to do maintenance work at Jiangsu Jiangyan Telecommunication Bureau.

Huaping Lu, age 52, has served as the operating manager of Tengjun Biotechnology Corp. since 2011. From 1996 to 2010, she was the owner of Changzhou Jianding Shopping Mall. From 1990 to 1995, she was the accountant of Changzhou Chashan Shopping Center. Mrs. Huaping Lu graduated from Changzhou LiuGuoJun Polytech majoring in accounting in 1989.

Involvement in Certain Legal Proceedings

None of our directors and officers has been convicted in a criminal proceeding, excluding traffic violations or similar misdemeanors, nor has been a party to any judicial or administrative proceeding during the past ten years that resulted in a judgment, decree or final order enjoining the person from future violations of, or prohibiting activities subject to, federal or state securities laws, or a finding of any violation of federal or state securities laws, except for matters that were dismissed without sanction or settlement. There have been no events under any bankruptcy act, no criminal proceedings, no judgments, injunctions, orders or decrees material to the evaluation of the ability and integrity of any of our directors, executive officers, promoters or control persons during the past ten years.

Corporate Governance

We are a “smaller reporting company” as defined in Rule 12b-2 under the Exchange Act.

The OTC Bulletin Board, where our common stock is quoted under the trading symbol “TJBH”, does not have any director independence requirements. In determining whether our directors are independent, we refer to Nasdaq Stock Market Rule 4200(a)(15). Based on these criteria, we have determined that our director does not meet the independence requirements of the Nasdaq Stock Market as currently in effect.

We do not have standing audit, compensation and corporate governance committees, or committees performing similar functions. Our Board, as a whole, handles the matters usually addressed by such committees. Our director is also the sole executive officer of the Company. Our Board does not currently have any member who qualifies as an audit committee financial expert. We believe that the cost of retaining such a financial expert at this time is prohibitive. Additionally, because we have not yet begun business operations, we believe the services of an audit committee financial expert are not necessary for us at this time.

At this time, we have not adopted corporate governance guidelines, a code of business conduct, a code of ethics or a related party transaction policy. We anticipate that as we engage in a business combination and commence operations, we will implement appropriate corporate governance structures to comply with SEC and/or stock exchange requirements that would be applicable to us at such time.

We maintain a corporate website and post our SEC filings on a page of that website. The information on our website is not, and shall not be deemed to be, a part of this report or incorporated by reference into this or any other filing we make with the SEC.

Family Relationships

Huaping Lu is a sibling of Qiuping Lu, the CEO, CFO and director of the Company.

Potential Conflicts of Interest

Since we do not have an audit or compensation committee comprised of independent directors, the functions that would have been performed by such committees are performed by our Board as a whole. Therefore, there is a potential conflict of interest in that our director has the authority to determine issues concerning management compensation and audit issues that may affect management decisions.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

Section 16(a) of the Exchange Act requires our Section 16 officers, directors and beneficial owners of more than 10% of our common stock to file reports of ownership and changes in ownership with the SEC. Copies of these filings must be furnished to us. Based solely upon a review of the forms filed with the SEC by our Section 16 officers, directors and beneficial owners of more than 10% of our common stock, regarding their ownership of, and transactions in, our common stock and upon written representations from such persons that no additional forms were required, we believe that during the 2019 fiscal year all Section 16(a) reports were timely filed.

Item 11. Executive Compensation

No compensation has been paid to our officers during the years ended December 31, 2019 and 2018. We have no current plans to begin paying our officers any compensation until our business becomes operational.

Director Compensation

No compensation has been paid to our directors during the years ended December 31, 2019 and 2018. We have no current plans to begin paying our directors any compensation until our business becomes operational.

Employment Agreements

We have not entered into any employment agreements with any of our officers or directors.

Long-Term Incentive Plan Awards

We do not have any long-term incentive plans that provide compensation intended to serve as incentive for performance.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth information regarding beneficial ownership as of February 28, 2020 by (i) each named executive officer; (ii) each member of our Board of Directors; (iii) each person deemed to be the beneficial owner of more than five percent (5%) of any class of our common stock; and (iv) all of our named executive officers and directors as a group:

	Beneficial Ownership
Name of Beneficial Owner	Common Stock		Percentage
Qiuping Lu *		15,000,000		34.7	%
Xianchang Ma *		-		0.0	%
Suzhen Zhang *		5,100,000		11.8	%
Huaping Lu*		965,100		2.2	%
All officer and directors as a group (4 persons)		21,065,100		48.7	%

5% or greater beneficial owners
Fumin Feng		5,000,000		11.6	%
Guangyuang Liu		2,340,000		5.4	%
5% or greater beneficial owners as a group		7,340,000		17.0	%

Officer and director of our company

(1)	Unless otherwise indicated, the address of each beneficial owner listed in the table above is c/o 527 Siltstone Place, Cary, NC 27519.

(2)

Based on 43,216,580 shares of common stock issued and outstanding as of February 28, 2020. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants and convertible notes currently exercisable or convertible, or exercisable or convertible within 60 days, are deemed outstanding for determining the number of shares beneficially owned and for computing the percentage ownership of the person holding such options, but are not deemed outstanding for computing the percentage ownership of any other person. Except as indicated by the footnote, and subject to community property laws, where applicable, the persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

Securities Authorized for Issuance under Equity Compensation Plans

We did not have any authorized equity compensation plans during the year ended December 31, 2019.

Item 13. Certain Relationships and Related Transactions, and Director Independence

During the year ended December 31, 2019, Ms. Lu, the director and officer of the Company, advanced an aggregate $39,792 to the Company to pay some of its expenses and for working capital purposes. The Company made repayments of $5,000 to Ms. Lu in 2019. These advances in the aggregate amounts of $272,814 at December 31, 2019, are payable on demand and are included in related party loans on the accompanying balance sheets.

Imputed interest of $20,372 was recorded for the year ended December 31, 2019, and recorded as interest expense and an increase in additional paid-in capital.

During the year ended December 31, 2019, the Company sold 5,000,000 shares of common stock for $5,000. This was purchased by a related party. As the Company did not have a bank account, the funds were deposited directly to Ms. Lu’s personal bank account and was accounted for as a repayment for advances outstanding made by Ms. Lu.

Director Independence

No member of management is required by us to work on a full time basis. Accordingly, certain conflicts of interest may arise between us and our officers and directors in that they may have other business interests in the future to which they devote their attention, and they may be expected to continue to do so although management time must also be devoted to our business. As a result, conflicts of interest may arise that can be resolved only through their exercise of such judgment as is consistent with each officer's understanding of his or her fiduciary duties to us.

The OTC Markets, where our common stock is quoted under the trading symbol “TJBH”, does not have any director independence requirements. In determining whether our directors are independent, we refer to Nasdaq Stock Market Rule 4200(a)(15). Based on these criteria, we have determined that Xianchang Ma and Suzhen Zhang who served in that capacity at any time during 2019 met the independence requirements of the Nasdaq Stock Market as currently in effect.

Item 14. Principal Accounting Fees and Services

Audit Fees

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the annual audit of our financial statements and review of financial statements included in our quarterly reports and services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for these fiscal periods were as follows:

	For the Year Ended December 31, 2019		For the Year Ended December 31, 2018

Audit Fees	$	7,405	$	7,405
Audit Related Fees		0		0
Tax Fees		0		0
All Other Fees	$	0	$	0

Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors

Given the fact that we currently have four directors, as well as the limited financial resources and operational state of us, our Board acts as our Audit Committee. Our Board pre-approves all audit and permissible non-audit services. These services may include audit services, audit-related services, tax services and other services. Our Board approves these services on a case-by-case basis.

PART IV

Item 15. Exhibits, Financial Statement Schedules

The following documents are filed as a part of this Annual Report:

(1)

Financial Statements

The financial statements required to be filed as part of this report are set forth in Item 8 of Part II of this Annual Report.

(2)

Financial Statement Schedules

All schedules are omitted for the reason that the information is included in the financial statements or the notes thereto or that they are not required or are not applicable.

(3)

Exhibits

Exhibit Number		Description of Exhibit

3.1 (1)		Amendment of Articles of Incorporation dated November 25, 2019

3.2 (2)		Amendment of Articles of Incorporation dated July 17, 2012

3.3 (2)		Amendment of Articles of Incorporation dated December 19, 2013

3.4 (3)		Bylaws

31.1*		Rule 13a-14(a) Certification of the Chief Executive and Financial Officer

32.1*		Section 1350 Certification of Chief Executive and Financial Officer

101.INS		XBRL Instance *

101.SCH		XBRL Taxonomy Extension Schema *

101.CAL		XBRL Taxonomy Extension Calculation *

101.DEF		XBRL Taxonomy Extension Definition *

101.LAB		XBRL Taxonomy Extension Labeled *

101.PRE		XBRL Taxonomy Extension Presentation *

*	Filed along with this document

(1)	Incorporated by reference from our Form 8K filed with the SEC on December 12, 2019.

(2)	Incorporated by reference from our Annual Report on Form 10-K filed with the SEC on April 14, 2015.

(3)	Incorporated by reference from our Registration Statement on Form S-1/A filed with the SEC on October 12, 2010.

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Tengjun Biotechnology Corp.

	/s/ Qiuping Lu
Date: February 28, 2020	Qiuping Lu
	Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial and Accounting Officer), and President

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

Signature	Title	Date

/s/Qiuping Lu	CEO, CFO, President and Director	February 28, 2020
/s/Xianchang Ma (*)	Vice President and Director	February 28, 2020
/s/Suzhen Zhang (*)	Director	February 28, 2020
/s/Huaping Lu (*)	Director	February 28, 2020

TENGJUN BIOTECHNOLOGY CORP.

FINANCIAL STATEMENTS

December 31, 2019 and 2018

F-1

TENGJUN BIOTECHNOLOGY CORP.

INDEX TO FINANCIAL STATEMENTS

December 31, 2019 and 2018

CONTENTS

Report of Independent Registered Public Accounting Firm	F-3

Financial Statements:

Balance Sheets - As of December 31, 2019 and 2018	F-4

Statements of Operations - For the Years Ended December 31, 2019 and 2018	F-5

Statements of Changes in Stockholders’ Deficit - For the Years Ended December 31, 2019 and 2018	F-6

Statements of Cash Flows – For the Years Ended December 31, 2019 and 2018	F-7

Notes to Financial Statements	F-8

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of Tengjun Biotechnology Corp.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Tengjun Biotechnology Corp. (the Company) as of December 31, 2019 and 2018, and the related statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-year period ended December 31, 2019, and the related notes and schedules (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company suffered a net loss from operations and has a net capital deficiency, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ M&K CPAS, PLLC

We have served as the Company’s auditor since 2010.

Houston, Texas

February 28, 2020

F-3

TENGJUN BIOTECHNOLOGY CORP.

BALANCE SHEETS

	As of
	December 31, 2019			December 31, 2018

ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	-		$	-
Prepaid expenses		4,299			4,000

TOTAL CURRENT ASSETS		4,299			4,000

TOTAL ASSETS	$	4,299		$	4,000

LIABILITIES AND STOCKHOLDERS’ DEFICIT

CURRENT LIABILITIES:
Accounts payable and accrued liabilities	$	11,125		$	11,125
Related party loans		272,814			238,022

TOTAL CURRENT LIABILITIES		283,939			249,147

STOCKHOLDERS’ DEFICIT:
Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)		-			-
Common stock ($.001 par value; 70,000,000 shares authorized; 43,136,540 and 38,136,540 shares issued and outstanding at December 31, 2019 and 2018, respectively)		43,137			38,137
Additional paid-in capital		201,095			180,723
Accumulated deficit		(523,872	)		(464,007	)

TOTAL STOCKHOLDERS’ DEFICIT		(279,640	)		(245,147	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	4,299		$	4,000

The accompanying notes to the financial statements are an integral part of these statements.

F-4

TENGJUN BIOTECHNOLOGY CORP.

STATEMENTS OF OPERATIONS

	For the Year ended			For the Year ended
	December 31, 2019			December 31, 2018

Revenues	$	-		$	-

Operating Expenses:
Accounting fees		11,405			11,050
Other general and administrative		28,088			18,848

Total Operating Expenses		39,493			29,898

Loss from Operations		(39,493	)		(29,898	)

Other Expense:
Interest expense - related party		(20,372	)		(17,908	)

Total Other Expense		(20,372	)		(17,908	)

Net Loss	$	(59,865	)	$	(47,806	)

Net loss per common share, basic and diluted	$	(0.00	)	$	(0.00	)

Weighted average number of common shares outstanding:
Basic and diluted		39,862,567			38,136,540

The accompanying notes to the financial statements are an integral part of these statements.

F-5

TENGJUN BIOTECHNOLOGY CORP.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2019 AND 2018

					Additional					Total
	Common Stock				Paid-in		Accumulated			Stockholders’
	Shares		Amount		Capital		Deficit			Deficit

Balance at December 31, 2017		38,136,540	$	38,137	$	162,815	$	(416,201	)	$	(215,249	)

Imputed interest		-		-		17,908		-			17,908

Net loss		-		-		-		(47,806	)		(47,806	)

Balance at December 31, 2018		38,136,540	$	38,137	$	180,723	$	(464,007	)	$	(245,147	)

Common stock issued for cash		5,000,000		5,000		-		-			5,000

Imputed interest		-		-		20,372		-			20,372

Net loss		-		-		-		(59,865	)		(59,865	)

Balance at December 31, 2019		43,136,540	$	43,137	$	201,095	$	(523,872	)	$	(279,640	)

The accompanying notes to the financial statements are an integral part of these statements.

F-6

TENGJUN BIOTECHNOLOGY CORP.

STATEMENTS OF CASH FLOWS

	For the Year Ended			For the Year Ended
	December 31, 2019			December 31, 2018

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(59,865	)	$	(47,806	)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loans		20,372			17,908
Changes in operating assets and liabilities:
Increase in prepaid expenses		(299	)		(667	)
Increase in accounts payable and accrued liabilities		-			125

NET CASH USED IN OPERATING ACTIVITIES		(39,792	)		(30,440	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Refund for advance for future common stock subscriptions		-			(2,937	)
Proceeds received from loans from officer		39,792			33,377
Proceeds from sale of common stock		5,000			-
Repayment made for loans from officer		(5,000	)		-

NET CASH PROVIDED BY FINANCING ACTIVITIES		39,792			30,440

NET INCREASE IN CASH		-			-

Cash, beginning of year		-			-

Cash, end of year	$	-		$	-

SUPPLEMENTAL DISCLOSURES:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

The accompanying notes to the financial statements are an integral part of these statements.

F-7

TENGJUN BIOTECHNOLOGY CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 1 – Organization

China Herb Group Holdings Corporation (the “Company”) was incorporated under the name “Island Radio, Inc” under the laws of the State of Nevada on June 28, 2010. On December 9, 2019, the Company changed its corporate name to Tengjun Biotechnology Corp.

The Company’s original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People’s Republic of China, the Company’s management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company’s plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company has extremely limited liquidity. Through December 31, 2019, the Company has no revenues or operation.

NOTE 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements for Tengjun Biotechnology Corp. have been prepared in accordance with accounting principles generally accepted In the United States of America and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission.

Use of Estimates

The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

As of December 31, 2019 and 2018, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

F-8

TENGJUN BIOTECHNOLOGY CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 2 – Summary of Significant Accounting Policies (continued)

Fair Value of Financial Instruments (continued)

Description

Level 1

Level 2

Level 3

Total
Realized
Loss

December 31, 2019

December 31, 2018

Total

ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2019 and 2018, the Company had no cash equivalents.

Prepaid Expenses

Prepaid expenses relate to cash paid in advance for annual listing fee and business license. These amounts are recognized as expense over the related listing and service periods. At December 31, 2019 and 2018, prepaid expenses amounted $4,299 and $4,000, respectively.

Income Taxes

Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of December 31, 2019 and 2018, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.

Loss per Share Calculation

Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the years ended December 31, 2019 and 2018, the Company had no dilutive financial instruments issued or outstanding.

Recent Accounting Pronouncements

Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

F-9

TENGJUN BIOTECHNOLOGY CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 3 – Going Concern

The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions.

As of December 31, 2019, the Company had $0 in cash and has been funding its working capital needs from loans from related parties. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of December 31, 2019, the Company had a working capital deficit, accumulated deficit and stockholders’ deficit of $279,640, $523,872 and $279,640, respectively. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

NOTE 4 – Related Party Transactions

Related Parties Loans

Qiuping Lu, President, CEO, director and shareholder of the Company, advanced funds to the Company for working capital purposes. These working capital advances are payable on demand. As of December 31, 2019 and 2018, these working capital advances amounted to $272,814 and $238,022, respectively, are reflected as related party loans on the accompanying balance sheets.

During the years ended December 31, 2019 and 2018, in connection with these related party loans, the Company imputed interest of $20,372 and $17,908, respectively, and recorded interest expense and an increase in additional paid-in capital.

Office Space from Related Party

The Company uses office space of a related party, free of rent, which is considered immaterial.

NOTE 5 – Stockholders’ Deficit

Preferred Stock

The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share.

As of December 31, 2019 and 2018, the Company had no shares of its preferred stock issued and outstanding.

Common Stock

The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share.

As of December 31, 2019 and 2018, the Company had 43,136,540 and 38,136,540 shares of its common stock issued and outstanding, respectively.

F-10

TENGJUN BIOTECHNOLOGY CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 5 – Stockholders’ Deficit (continued)

Common Stock Sold for Cash

proceeds of $5,000.

NOTE 6 – Income Taxes

The Company maintains deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets at December 31, 2019 and 2018 consist of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty of the attainment of future taxable income. The provision (benefit) for income taxes for the years ended December 31, 2019 and 2018 were as follows, assuming a 21% effective tax rate. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended December 31, 2019 and 2018 were as follows:

	Year Ended			Year Ended
	December 31, 2019			December 31, 2018
Income tax benefit at U.S. statutory rate	$	(12,571	)	$	(10,039	)
Non-deductible interest		4,278			3,761
Change in valuation allowance		8,293			6,278
Total provision for income tax	$	-		$	-

The Company’s approximate net deferred tax asset as of December 31, 2019 and 2018 was as follows:

Deferred Tax Asset:	December 31, 2019			December 31, 2018
Net operating loss carryforward	$	88,094		$	79,801
Valuation allowance		(88,094	)		(79,801	)
Net deferred tax asset	$	-		$	-

The net operating loss carryforward was $419,496 at December 31, 2019. The Company provided a valuation allowance equal to the deferred income tax asset for the years ended December 31, 2019 and 2018 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The increase in the allowance was $8,293 in 2019. The potential tax benefit arising from the loss carryforward will expire in 2039.

Additionally, the future utilization of the net operating loss carryforward to offset future taxable income may be subject to an annual limitation as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.

The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position.

NOTE 7 – Commitments and Contingencies

At December 31, 2019, there were no legal proceedings against the Company.

NOTE 8 – Subsequent Event

Common Stock Sold for Cash

proceeds of $2,405.

F-11

EX-31.1 2 f10k2019ex31-1_tengjunbio.htm CERTIFICATION

Exhibit 31.1

Rule 13a-14(a) Certification of the Chief Executive and Financial Officer

I, Quiping Lu, CEO and CFO of Tengjun Biotechnology Corp., certify that:

1. I have reviewed this Form 10-K Annual Report of Tengjun Biotechnology Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. As sole executive officer of the Registrant, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. As sole executive officer of the Registrant, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Qiuping Lu
Date: February 28, 2020	Qiuping Lu
	Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1 3 f10k2019ex32-1_tengjunbio.htm CERTIFICATION

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Executive and Financial Officer of Tengjun Biotechnology Corp. (the “Company”), certifies that, to her knowledge:

The report of the Company for the twelve-month period ended December 31, 2019 as filed with the Securities and Exchange Commission on this date (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

	/s/ Qiuping Lu
Date: February 28, 2020	Qiuping Lu
	Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial and Accounting Officer)

GRAPHIC 4 image_001.jpg GRAPHIC begin 644 image_001.jpg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�>-\ND9N0KKWF^M3WJ2KH7I2%A* > T.BQ!XK0; ,R%CHY5//>I[TB?4X5$E"Q)!T+QRG)04BT'?OU"#<:G MO4]ZL!N9B1RZ$20 ^/5X7#>IHH8*Z)!^ !E&#RB.0$3WJ>]3WH3%2RLR0*AY MHAPDG! TS,I:CD5#;Y@DA278(S4M?E(!,,5Q1M%3.[]PWD@07O.LZG4_'7PV M4#);8=@&563. :Q:KIEJ>]3WKE[8L!S%*][W\%K3H@6TFPJ"[C+:I[U/>E/V MD+"4(\CHT^[A$M45;I7>M?:8&6Y.'X89&I[U99V0JLMY:ZE1^T)-\K6J7,S% ML4_D$L9VWJ+DL;$?R+LHQL4M3WJ>],6BD*7#<,PPC*"+%@L!IXHZ0EL!#H7";ME;65D%+/"IC]Y5==X@6].KJW01ZH38W,+"!9V(T=1HUC9 M3L0042XI,KK<8H3$#YEE[6ZXL0+I)#-1"&T/6:"; *G%,IBR!$3T"B-D",&) M%DZ%*I*2D3[_ (D:'IG1TD"%$(@D,4YF(PG"V3:!V>H8#0%^(Y D"U0*^TLY M U#"A-!$H0OMVNU$@AZ,99&/337<%D*[ ^Z<'C+-<(U>N+$%;:)O&,.[0\!: MX'E#"E@V1I84ZAP<-,<0F.N+$M%[EMO2X(O:D)T4"6P75P%9YR*4%B1L8WMK MTH$4]F@ERX<:%NK]@9G"%=PC9*= *\0HE.DR] [[4#4%YM*&;8I-3V0<$1E( ML(VZ>YU. O@.[5ALI?'D!&("\0G)BV83KV14#?@B9M[8@( VM=5]5N^'%BQ% MP&%LZ$2I/B+,K<6=(4#4YTZXL4ZWCMY D##233Q0<;<]Z!FU<6ZVZ8L3/!7X MTH7@WAF>G X\P6<+"$&EBDS+04385:,'?BGR5*!,)TY/ I=!25B??\2-1SX, M>*Y_0(M*TMMP09(L&;^)+U#TR#(&7('1&R%J+%@'O$DUP'[@7=;B#@.S"5TH M^P$2Q;GD33,ZR0"P(KH;MSQ60 MB!D0]9W"I5 .\A,E]/*76"]0Q"S 3:$) M;V,:/^9*]DFCNL%:\L/OO+W]:G.B\X+AN$"G+ZR(@]B6W*VTW@NF]2M.R Z F,3%DE19Z"9K MU<"-E$Z/[80L@RIMX4;UAPL4*,S1:1#*H]L%CPV!6N%^4M.H#>M)'SZN':]: MEU,O"OL 5!2HGE][VB31FH.,1]#K%1(.%O"F6 MIX)2,#>S;03W,RK[#K8J>6X[6@%:@0>"H_(X&Z>^ M@ 0!8 P!M^MS90E51K3=VH(E(O'T;CTJ32D\9$V(NM1&&&) @> IS5#L MI$P(&$)$X3Z@+Y/O5KD'X%W$]8_50*L23'=!>Q4]<"%).?B54ZTM\HBN5 M;Y#EL-UJ=$95;E!K\81O%8RD@;LL"38.[?\ 8@H;+G&9O9PH ( L 8 V_8LQ&WP4I(D+*6ZXM&6HW@3F+@"ZZ!6JO/ ML_B^F#D9N+ Y$[F=!"((7E0\HEY^K$=(,]LP#I/(K*X4<1LX?LIMGV MV]0* M>"[@IN!O*)J*C#0S=_DJM>Q6I:#&\_V#%+*WOL.M=[0S]8TM8H7CS@7 MSBI>+?X.\I>0;*?8I#7O%R[30"7U!]G:E)41R.U[4Y($VTK%E#WJUL[K/JUS MYX?U:QE).<:'['Z2DY#NQ>PXW >+FR#@W4"I$2+Q3-H+%WE 9S"#L '[%FA M+A2I9"PG-,I40^RI:>*4&0F7-!;&Y H>5T9Y@N/LVLM+]0'(S<0ARES'\&*0 M(I 191#4DN30B27&XF$^NGRD?>G1(,<93683T VJ/&8LC2?;COKX0G(C!^D3 M)U;[E#TC\[Q>X$[4XDJIN#^RZ9L"IRF93K28OC<'J$:(G6!GL(/JAR,W$&8A MZ<0I/%'-*-E$CD2B?D O#=VEGL_HLPRM$G65+DO4RNWN2FSZ$SO#@[=0X?V#PQFZ.]DLV:1N1%(M#FUEWVDO6* AH>'L0]E+#'I17=$#M+WH9>HL M"S?4P*499!LF #6"W_$>=A16HU(S7 [^3![6\/E0(3,S$=WBDD\["BM1J1GP M23OE^V/<1&F>G([[P_G;5_'AYGVU\-EPUP%0VK@K@*X>D[&FI$S_P <)Q0M:!^NI3LI1G_B M>P4+-_"C4-*ET^6N6N7KDMJAMTQM? K%J[)_PN$KN'5!FD:4K]>4Q0-&XH3H MK%FER_X$%L4)?J2Q>E/TPC%"UHJ:M,?OS=E!A6*"CD?J^P5A6-+V?OFOT"45 ME^O&=J8?WD"V**[6@[J7+]CE_=P5!1#S2N,?\V$U$17.?^:O^_B+WB*_PZ22 MQ=I^U$29PON>+*SLJR.[?U5@]W_JIB$7)'Z7B685^*!F'RONBO-G]U?2&\Q[ MA%0)0;_1.,D%^+^:_P XK_.*_P XJ>^RL82*R[E=QA\&0H.PU?0O0B <%?YQ M7^<5_G%&,0?=E]0!$G\NO\XK_.*2 ,-/!7EBL=/Y-%'^<5_G%*S1*H0!EJX' M",1/+E^"V_T-W8['=P>M$BNW^K)]/519]V]&P!P1X!81H(WS43]X?-($=C/I:>B4< R$;)X8HES?L/D7K7^<5_G% M?YQ4$P/#5=]Q]/'RPC@-UI]W0: /L!]-?5Z%<'. 'L>#M+@?O5\) G*65S $MCK\] MO-B>* ( 5%14Y<5YH?:L[V:7\=W:+ZO)O@<;_ XB_L@>=-W0J_(+[AE_@V(. MO=9OF[O[;3XS%QV1L.<#U=*'H> -*BHKG@+KP&5X)::[\8>@2OK1RU>3-7+% MY,5GP@;S?8I)VS (@_HPD\0AF"#@4W4!E<\V J)%WUN[6?3L*#L>1,/GXZ@K M ?9'UZFF05Y-Z].HXP>J*_%NNCQ#NV^!?7PFOC#Z?S*>Q45%25S@R<'W6QZE M>\(/O#XI267?^J4E;.;Y/>F!-^#VN^0\5(:1Z2U'>)]?H3;8O=_I45%3LO\ M _PJ14:DN]#^ =<+;'JQ5L4P[!!45!'WPS_8>E145.-W_'\>#"$;X.PU?!JE MJM1NT#T/O+4>N;C_ *>Y0EFE>)N1;L@>_A\HWU%1UQ:0FU]WO_%NU%12B^K> M8L96W*5?N(OG0P&A;Z!%8]^<>A;O.]145M56^_IJ_P M+4M[#8:'EO\ 0BHJ M*\SW=9DRNT1"'>1].:BHHGOS77VU-Y=5I%15V;0[3]F'K45%0,PGR[/=X0(U M7V?VJ*BD7VN-U]Y]OJQ[@/8_OU$T:7U4?R>L'_B%[3'ITLA<>0;KTZ.;)2]B MMJ">\/M,=8$W^Q?QULRY'877H#0[AP'G75=6]3@[$ [LN-D7U6\!Q>O=DXP. MVG#6-H)_3R8>:2E'ILH'O?U\'F&_P K-X'FT]?DDK%C'0[@)7SJX#5M3"R+> M8NY6_ ?0,!)]-_-$>O6:&C+^@U^YWC3ZGF>[J[&6?5'\]34U#Y/XZ[.+U+_( M].#R[K?(4^=>V,QZT!7D3T);4#[GI!I%8!X!_.C?X=6*#0+C<;7N/?>W>0.O M(X3D^I'OH>W]W69+)'D-9ZQPLK[J3W/AT@)^(NC'UAA\6A&Z_GZNX6>R_OJJ MLM'J'VGWK-01W''4O]4I_P S3_P),?L^#S#?U$ZRARU:-:[W\_5>9[NAABH )5X*116'@,?SY;P/4!G[<_V/;I. M!(\Y:Q'KUW&)]W[O9TGV\A\3[GKU@-#>A>^T'IX'\A/(- )R.KX&;IH!/G[U M);I/Y[/=[5+1S\YKZ!]*8W'X'\=0C9M?QK(3T@_\ OLOB7I6;&:'7Q/>/ MN9Z3I8/J?8CW>!R'H5*.(X-UH>K: MH^H_L&K]VL KZ;7U*]H\'D&_QQ XNS_#EQ&WT02:_P '6H-C]W\?5+"&6[NW MM66";2*F_,'N2^A;CJB<"2NQ7]?R:^J7U#3I*%MU'(M9^M_LCTZP_83W> PZ%D31H*&,5OZ..'V'@BCB]&]'5R6W-:8@^$?/LX=/H"5 RWM+P_#K!K*CY!<)]:=G7JI=H'N?UZ@G0LCLTZ M;6CAJ<9<8TH3\*S'R$#M#F]35!VT.P:O!*T*R:K]S;Y-=O#Y!O\ P#G+8VZ MFQ#1'4;)2BG4;O'J8>3Z ;SR?CJ\?+^]?#^A79:*P4*S]@?Z?-UC'6?;>JOX MB#TZ+!-2?..5/0JGOW+B0O9GTZQZ2I>072/$>6C16'EM+B*/)/R/?+T9XJ? M]/*[-WN,^S7Z$%YONW\U%14V\K-2TL#WM14\$3Z9HV8<)LED^C%144N'&1'*43)J7RAI60BY M$_"/NK@1# ["Q[=6TX!^7P-$"#%145%145%145 I EY!88]/&H6'_98](>:+ M#LGW6_+T6]145%!:CX[OX$\?>*]P_P ]"9P)\=)N8)/(,/4S;P^@'P=)@W3V M#[B^SI!'<_L_QUG\P%T\T+(]4>JHT?8@#^ IR5%C@W>0QI69T?B\GPMLA IX M34:D[HM:G4Y_+A(I\CB>P^:$NS'R[O9T\ZW]4IL8_)/N6Z3AI8.[A_)R%+ ! M!W&X];$7[^XGV/X'C-!!C[@]!GTZ144LG06]CT:OJ'E^[QP PCR[/=]*%-D[ MA]P?9] ZB)(F1,-9(F]P7[U%11$.;GDVCQ\7#V-15X(A/9]9.9/Z'\!J*BHJ M2$^D+7WD]>D 3GUKW^*BHKG _,?STO#^I>^]O:MO1]POAZS!5/H*P9J,@0BYB;3?!G'6*BHKRW=X\,F+LV^ ?6HJ*DH#D:F\('&+4PJEP?8L]12(PY MZFT >(_G9J[2U;E,.P05%11W9*.2V^WC88L'L=);P>[.LZLL\NSW=6?E$^ ] M8%)3<70FNY]SZ@G97Q_ST O%_4E %V+QLI9]&] ]*(V3K9&4\K=7.A%00NCH MMNSPPZGD6_Q6EQ@P_IX+"ZCNHJT^4=A!UN M=*X[+? >":&/2%I[2>G4 W%2MX8/N>L'I=WVH6_<^O3.;RGNE+SZ+[ IJ7>5 M (#T.K_6D-99[#?O!KX^'%[O6;=ONAUA$^0%GV3UZR/SGR[O9U11Q]Q. ML5X/LG2Z=.YN6'J>S#1/!^1V34J^4)HML#]L@W(#D)P3YOXKO!9"]")]RBLL M7R=AH^=UH]'"5;_&ZFTNSQV>FW<- M^H1@$1U')5ZV8W>G?!]]?"0-"LU,Z7GP?P["YVD3IO7V&SD]0J:FIJ:FIK> MYWE'S'B\MW>*#*Y]3^Q>J+;%AY#*>$58!0#ZY[Q9Z,G6"V,^7=[.AE_S@7?5 MO4U-34U-35TI%CR!RMW;4R[88VC^75\9KR@;R&.N&!M5N42P7X.M@ 8[C-^- MZX_=KQ^[7 PH$$2N[>_41R$@RQIUPP,Z4%8"X?3KZR4O2T>2'TH<:YM\Q0,3 M4ANP'^\?S3*5=WNQZ!=J,Z*F9UG>:#6^C2/>#>^Z]UR/ W%IH4_#9:C8EE:2 M&-))8>)>[2CSB#-PZX8&D<)4@@/\> RL%D=DHY)$A(75._7# )>8[9L>$^0\ M 12BEZBK *+ AI<^V/@_-.UC$U J4/9JV+LP'NIH8HVI]];V#S23*94KW7 M]P!;%!-2D7_-KV58I%_S0+BH;T TBE_YG-+0 Q16&:5;OZN!-<-<-(TI,N@9 M4);PI!HQ \*84#6N.N+PL&+BLATA^P@N.@!ATT_UK!VILJY*O12!'3!K \.# MM67P3.*L.*6DFM2U8CPBESHH*.E3H4HS^J!<4-F@NH=U+E^NP=JS^#)WK!K M\.#M67P"*7OIA84+FW5;2G0IT*2T_1"8**@:M Z>!&5*XQ^P8.U9^DSBE@FL MU@U@>'!VK+U+L=%EGZHL*"@CCP0-2Z=#NZGPUQ-<#7 UQ-I7/[7@[5G\.#T\-ZAO4-^F#M4J:AO4-ZB32*2APKN%<& MI;U$.?\ B+"(BI99\/$\5581$>"K9(Z=JW>C.E>SX/_: @! P,!/R'_ (28 M\,*52U+4O#"D?^.4,T[*6^N!1NH1Q_Q*"EN/%2J'CJHAU4O ,H#_ ,*@I;U! M<4;J"_0SLI+H,H#_ ,#BMGJ-H)^F0A[U&0/W/BH+?*_ MU4>2]D\.+N*U/-R_FM5CCS_TG]U_I/[H\/@*5; $Y6E,2&A['R#N.('CV M@Y-TV"4[%M;4478_5%]YVE/!#J1Z3!]!X2D<\RST)J$<;B Q$N)O?,Q;IB$ MVC]A/A27=XOW\$BPZEFE2P:OI6!Z115R[L'*C7?;6[V&H*0 ;I"]V1Z(FZI7;JO>2^ M#RSU&&_K5]8%@(!HD0ODGZ"-\.DE_+#M]N >!.#,]"OG['PS%N/9?Q^B!5W, MR^'R3:=MT,33U%4JW5F#P85Q>@QZQ M#2XRY;A)\/APV<:CX>[G:6!6#R [(] ]UE95?' >_8!^5^A.$SV+J%@1;[]$ M567>].[GP)QVA\OH&$Z=2/JA\WV?T,(N4MU.#[K@,K 7J1P:)<'^BU2Z]7XB M70OWYM]M;&+&/&EMN?KO<=]UI"*FX&#=?.# 6+=1SWH,&ZPRI7M']Z]U&/>?ZT,0+I!^=I%(G$@5L7-J'CK-34TJE%*7!:IX+Z 2RT>1](B[#5;>J11,-@E[D?T")J:0ALIS'\O5/: M\[G8>PO7]S3R>W(NW6<'W0MN[7L\*-,QY!TLZD()A:RH/0"'+?ZO^YD'EQ4< M5'%)!R)V?RA=VHXJ.*GE,'OX]WW.EY/5.?\ <;BD<5,R,!NM@H/A)[LE]1+4 M<5'%.IH/F_GJ4DX&[\I [%Z<7(C?^ +!@ "Q41-I%#<0(]4#8+2A0G8'2<;< MB=@WH1X5M6U.!\/I7Q[J)/QUTH?)7!4AYB=PG]_)\%W5(D.1'!\VQJVJV5.-JP]M=TZNH M@L@1<71_E[9?0BI_K7[CJ&G* WL'9%/U1YAMZ'#&4 #=6P4^3<-$VALP$KPF MRCJ*8POJK=I71+2.:X:H15QSVSXGKTBQ'H3XA'Z=2:T^L7'4&%B/$_9]$I3H M"FRI'WK%2%/0?F0]*:.#S76^PU]!+4O+U!=> .; =BLGF\9'PDTD4SX:45%1 M45%163"7=,O,(:A]%+H'S/\ 4J*B@9UOS^D145%/HH!@,!!.[M':N?C2>V'N M-(YY(8#VI&Z+S45%#S40!=5P'+4%SS$XC9(IGI<_,G[^9M45%0"]60M=KAT0 MMR]7_5[JBHJ85@//W8^" ,$B-Q&R)LTYE6-][G8N1QE%145%8N9I <:=_4<. M.Q9('32&'\Z(W&S?Z%WL7K&^ #]A48$$^\?S+OTIDGMXIZEJ!Y 3X-//P2 E8)?8)ZZ7" 9 R)V:B&!9:&?3V":S] M!'8KV?[G7*:@/?0^0^E&HU&HU&HU&E"/ "KY^*+'N_DG'(6W&_66$^A]+A'J M=))BQ4+UOB#WQTHQ1R+4X!A@W=7(J ?+]B7IXN+!-[T#U2U9I!4&\?6'>F'- M66<^#X(5OJ6'8;<,?0.*@\EM4U-"!@![5#:X[!)/:&DU-0Q(#RR'=3W*FI ) M1\O7"/7HPF%_!_-34UW"'V/]]0B/'/ 'P/)+8BSK*4Y3@-50#8I7"KF>R)9$ MPU'B0PEW6U'>([AU/RPJUQ-)JM.$K\AN=6DU-!(U; &5K\[$8.=7O;$G"1$1 MCX(9]9"DU-1$"/;_ +5OSU16;F/&A.Z[)?W)ZU-37SEK@4]2U/>"IN$CZGT9 MJ:F@D1!'DQ[0N=DY\R^9J *\RO5@TZCK0?"?5A3)D6IJ:FI MJ:FIJ:E1(?+]TGL^-A=O\)GM!Q2MQ9A[4M'&VY9,U/0[TS3?^;/'VQ_=_AT8 MG(_<=(/)3\E7 ZLK;#W_ )GI&"Q+S\L#I"^Y?9_/63-#\G\/1_[+M?T/0C6I MU/>$/E6E8(QY=KZ9NSJM,H&>?R$ZKFHJ_21D2L8;?<6IU_DL%:0V1#Y[1[E0 MD.8'D0-.1*>$K CKL9] MNK9X$';^V?'S]O=.@6R04;SU(X(\DG6> 1PCUS<>WM.DLB9/:Q/S'KU+I1%[ MV/X3Z=+?W/+8>U_>O[ \4_(ZP=#VSKX_S;0T) YV@]P/J-1=DF(87,@,"&RL MW4]PE/L:<4+,=U('L&1I+PE =4= "CT_CKN35U&^3C1++V>S#D*@-"G?1V3" M:(GC2'E=@_@J0TZ@=@HB,(F$=$JPB6"]@NN#LH 2=$/H1L$HV4H M]'Q\C76^;LWZ3%=&]D_CK$3.=Z/M?3K0=+!\K]"M C@$'1LZA^R?QUKB8'R? MQT.3X(T(E)M.X-SU)*( >AJ-SK)33" TZ0U-/02PCB4E39'//$1H]3"ZI2#] M1,65]34Y&XZ(-:<'G9H<"$ZT]UADT^Q-SAOX]H-7USP/LFJ2I4(]!HFN@^C# M)4ZG4ZY8PR]T-%0R-Q]NG\=7V"O*Z>YIT,D^#Y/KUG4ZG7FVWQ9$J]@O\4E, MO6Z2_+UJ7"/7G^6^")$^J+GO[SK0JV&2C+RAXA!])'1YS^3A]@:3K#SL1[## M0,/\O=J).>844CSP13W6[4ZG5W%#:0QWKV2\;(=Q["]>"%\O87^.HJ#Y*_J/ M5Q1\TO2.H\ N]D_CKQY2>Y?STM '8&_H.=R36G=NAYV1U61UHR%Y?L&@IP=K\-09= L>D$WHL_<3581S6 M@GGS!N]7HW.AGK9Q>"DCL&/N?7?NV==ND9$R)<3LU:3@]CE[8.\:/AG0Z6RL M%GXW6JL\,(TNRQS_ "/CT.50J%0J%0J%; J>T/LGQ?R/9XIY+3TKWP+JR9)0 M\C70\*(I13+8 ]5WK!Z\^_YY?:GLK%W%)]F,*@]""H5"H5"H5"C\,MMYC07[ M%PJ.7[I?P:%N?&R4>H_RC>@1;G;GJ%"Y.;JEF S!: MUCOU9D%5P*6?3J((M&($B&3UZG[$T':=3E)ZWINZ.O[IY.E),-=1[N^TE^*$ M0_9#W,^M!UH'( 1&D;1M3>_M /,3KU$$)DC0!7+K< ].H@CHR8!(5);\$>OB<0V +-B;=CTZB"(WS( M#41OLGM/1E$?Y=+>A0I;"E_B\BE-AKJ4".X_?[:3GN-[ BA [T?O'R9Q1TY6 M [!;]PQ2K"A!_S8'>KN@'_-3&:V:%0 _P":=E*N:E[5C]6N>M"UH1QT8Q3. M?"S4I/"H9I6G4#P2;5,H-^PJ&:=E*N>F[^MU /USGPACHR\+GPREH:_30K+PN?!..ACZJ#FG941GQ$NB'6(5)4E0ZE#JI7Q M":#K^Q.:&=*[4%]>K+PN?!8?HD4L_2@N*-U /V1S0)XAEX7/BE)^BS2:EI]8 ME4JAK4#]G<^,9>%SX8PU%9Q^GATH5#P"'[=#GZ@ NO77KZ-^M>NO77KJ]:>NSTMX7_V@ , P$ A$#$0 $ M +L=\FKE M NTDDDDDED\ M !+DBWD\S70\D8 !LE.< * M +Z MDD@+B30N "2@ ":DD &V\ $VWP !F\!JV@ 4VVWT-MMMLP,FWF M !"VVW0 ]EL %AM0 ]L)-JP "F_ ! "$!4 * 6 &V *V@. & !@& !-IL@\-LP%1!@!-DI MC !FZ "20$30S@QO &YP !$@D@T*E@$P- !TDDL !6^ "2 M!^30DD.D FWJP P PMP< @+">0 P ( TD -L8MD1P $ 0 "DD M0@ 0/Q.!8 P!2, !@ :&@ !"2 &VVV PDN NB2P !-@]AJ'M0 M"]@%@MH]MV !TJ0 /_)XP#-MMM@ 8E: 8!)#())1^V:'0Y(*). ! M\ @ $E@ #))))( &@$ 1@* &, !V _/PP$ @-0 !(H@-P !@ ( MMLP*!;@&) !O /_>%_A(0/< _V M^ "TD&NP$DP 3^ !/\ 49:Y)> M#?X"?@"_L'K5IT3\@#_]@ #[VVVP#_\ &_0 %W_P#K;;2@ -^ +:@+_0$ MZ[@D_P! [\ 1H CLXB#_P" "_X '_ !S[X. M "N !RP M !7( M !DL0 )^ ! 'P +(^ !? M !KOP "=@ #*I)<@ P0 M\L X"X@ "U)7?>"Q$7'9))#H E0 L X"Z M /II))))))))(< U8 L X X@ KII))))+M> M P L X 3@ $_DV*$ M P HD@LGX,\@ #T "6VCV MW#[U@#__V@ ( 0$# 3\0_P"$S;$/GEN< 5<4^O2GR-N=1:6R=YUT/3:K,@+" MX.'TIA#"7*55 TU@"PP0$8Q3:K@N&2S'9X8JTAB>H"(S7 MYG_$P '2TBT1(8A,)P*3M[8E5C!*$4TW%*; T/EU&ZKU%18!FG$-9C:BH:)< M3QLAHX]JG!T@$7!3%H,76+U 8_4K#CRM+NR@.)_P"%!44G\P,!=+,4FX12\N%[*2"G1!$83-+- MVZW5UZ.CD[Y4)%I."?:IP&;G/F8L?6N[1%-3(&" M6HRG-"Z_\ Y3-]EPU?6&TP H;%BC1,I?W9+$D;&%426D(G<+^KQ#0?J MPYBT:";\9$PL@%1\^PC.&<4B5TD)'%;ALX.;"-Z(#L4KO #IM6V102!J2T'*$04IL+?KP07\RC08( M""W+U-1H@5@$J:&5UY4/)G\_O$M$QL&!Z "K %8J%Z^3Y'!0 E4% )+0T$MA MDE"Y4Q!%3,& Q( .(;H8)%O^Q)-FXV1_>(\HE2AN08R4%@% 1-%(@;1$906" M4&RH_1IU1C-AAI@0M_SAD8#+%6Y M$'1PF%(U!$3X43.0 $H0 "[7D',X/F)B3>@D8PPU%""P)C$TL'BBN)B"2E$Y MBM+$KY;!853<+?I4"XB&!($D$\*CTDD<19!0)? F1"F12V4?0%NP)=88;5<+ M0K]LIQ)22?1=%;A$+SU,)D#P/'CSNR@4%!?#:A?FH";552LIX!8QCZ(KZLP0 M2F:5=LXP6 45Y? \>/#O050[)5\Y;C4^H&?X=C 2(C>YU>/"C?#T$"4 W,G@ M>)ETW&1R2KRRCE0"DF"3D 8BDMU)^A&AX8\ _XC)R4$2))9^@ M+0!@,A11:#@W(13I8%B]>6?S7EG\UY9_->6?S4>,4;SN#02P%J-3^,'-\"%L M,13BK';8.R\$TAM:BH $79'*TRF8$XJ.[R[5'=Y=JCN\NU/&67\2%0L;)6.3 MCF,2NTHE,HNIMIHU@%CG<8P)A5WZ(6Y@3X: "'@"3*)MK#16O!#J\>/+6EFF MKK"CA'C;R2P8!"7H$(:)LX;;X9 !C6#>M2$^9=NW=U7EG\UY9_->6?S4HG,/ M0$&BP%@1+5!\&D!EH*!(:$?']\?))EMRS[P]7L4]7L4]7L4]7L4="/PD9)A# MP"@9>!7?$!:[(%RQ#!2WJ]BGJ]BGJ]BGJ]BADV.BBBYT)&B_4X,YLAS7J]BG MJ]BF;KZ1HFW529==@48RZ722DW!^3YGK64*LUZO8IZO8HK4O#Y(0FBA)^@"9 M(3M0V!S-5,8E20 3* ]D"J258;_%0W^*AO\ %0W^*AO\5#?XI+5F5@X(0EA+ M9T?D"1\'@! %@Z=[1WM'>T=[1WM'>T=[1WM$*5C((H$J,5$(J,W[P[/$"@ 3 M"")U3/F,/O.'S@I?ROD*3FP@D P@"O5[%/5[%/5[%$T@Y1#2IB87%"(I7VZ" M<^+PI>R^%6,M/J\.%(B.-9S*FW',-4W: WT-_BH;_%0W^*AO\5#?XJ&_Q5I0 MKD)>A3\TD=;*F3)(Z81J'D_-6JZXD1V",R MF'@&_;;..$=W4HAY/S2*3?3 ,BD@7 3DJ'D_-0\GYH2Y;""ML=N5("1 +]/C MCY"_FH>3\U#R?FAWC1V??CI?^9%B29S*1ZD+[2^@X;<("$PBAY/S4/)^:)H* M87])D79E,"U!,X8 0! @#'CDM^(.11%4&09\UAI*K*%'Q TZ"86RSA$F"I1"(@*YDCG M2[!'EEC:0K0P=);GO26Y[TEN>](!;@F^SLO DR@@PA!5 )3$$,2&T,)=N2.X MSQQ-JD,6R+6(\K22=2");GO26Y[T&M[N8F+(E>62& =231\")1@J]1!!DNAY M/S4/)^:>R%K,(0#IEE+2PF'D_-0\GYH+UB\A5;G60S0> D=H\&)+I0PH%3D* MY"F%SXX?NS,':KA'\))!MD&$"Z5@(&MY0NDKHW0O$C)E )@[$RPJ#72*),]W M&!K*@^R[P74"DV9020GZ%QI<9%R2L<2*.S4MVDMVBH+LH8.L F H$BI;M!=4 M I0%3(*%E,-IH0""@1&1&XB61.@@RO 6 "$4 5!?ISI"RD?6W+!K8I849 M;M);M+*!E/\ >B2ZZH%)NEG\N@\^Y6JB^-4ME1!QAIP7F,=WRT[OEI:&*]<* M*O@;@P=DDVX#-:.1/H)3N^_]UW??^Z[OO_=.4W3K,-Z+CDZ$8-3"&O=]_P"Z M[OO_ '3;A)G-[#%W#.-;BG 7,P&$#X0M1,5N7<#$86"!7=\M.[Y: IM4-]H6 9#$M?J2'30V!%!@ MA+),$WEN?%2W/BB?'BS-"%E@ @:2W/BI;GQ2M5ZCRPJP!R["=&ME/0)'6-]5 M-:EN?%9HTXHG7%"$M6$P'DN%%MV:DA$MSXJ6Y\5"5(X2\B)9! 0$2*] \V!" MLP_)83"J-#]Y087 756 DJ MT%U1("O9NF5H2_H2W^:2W^:2W^:*7W7KVP5 $*OQG@:R#+?YI+?YI=*L_$D2 M=2(:)E!IPSGP(J" "5;!1*B5)EJ81T(", 5+<^*:9@HS(3')(PO:E>+J6VC1 M5 4*7*,Y)9JCL$-$J6Y\5((,*=K#6//!Q3DM]HD*6 41D\ =& ($=XDHX:$ MMSW*2W/@23LJ(\3+OHDN.'4/\ ?XJ'^_Q0MN'^_Q4/]_BL%1_T,H0 M$D?2K")X@QTL=X9(1N?1AY*AY*AY*4ONO1B-W^[>SI%#+0H#;RD @,*T,X> M2H>2IN?,B;6 ]4RD7*E% YC"!15-I$,0P_W^*A_O\58B1.3"C:PF\@Z*-S1C M:<$<&PL!@A_O\5#_ '^*."QYDCQJ0RZDJRO5?.DKV,V[7)3$-GGTJ&SSZ5#9 MY]*MRJ**@"EF8R$J-N+J"";LK*5Y[T4B0_4%$8,JX%8ACZ*2R[H%D@HR"AO8 M'-\_FN;Y_-)R,,_RT#*0W9O2_YKF/?\T\U-TFCD5U<&I>?(!PP(S/#A$U(%Q\J"M6BP64H\Q[_ )KF/?\ M-";C5@K$Q:, K3"& 8$.S)\P;FC/(2,7&DPR) YCF^?S7-\_FH8XUE8<7= A M.O3.F-R4D 9 E""1@IS?/YKF^?S4!J*Y$&2+S9+1'G3/U4/*>PC*A#, Q-2.[SZ5'=Y]*@CE$9OFI&"H 75JHO,+D1D,95 M'=Y]*CN\^E*1(<:8,I%*0$)*23T"+XA](?G* B- >=T6G><@I< T6"N&QVLS M95IA20)@A.#JJM(& /9Y+:4 .*=XC/":<1\YU'=Y]*CN\^E1W>?2KC,Q0]ID MDA5(%(F0$!%#"(DB-1W>?2G,W8&KQ4]T"@=:%""NPN9@F#/'%@T8]EN+E!8J MC'0#%J]D,_8L @A])'=^:CN_-1W?FH[OS4=WYJ.[\U'=^:=^X:*[BZ&9,*$F MI&!G)8\XNWJCVAKU2$N1(KA2*CN\^E"LTD($G !F0@L.*D,'J@V#D!09W4)NH!EN^WXJV7W)![);&;T M T>DGF"-!AM2-E=*EN^WXJ6[[?BDB"6D*!-H!*R1I9MT:B:_1@Y\L"*&0Y8E M"DT3&7O;C$0>:L,2 B&D&PKOR>,MC1-$ZV^:3T,38S5'J[* I$"F8@0S8O'3 MC0O<:EN^WXJ6[[?BCT^3$#-490 *T5*+R=MJLM:+ED1&;<6[,50Y);OM^*EN M^WXIP+ICT10C@"L60[('APF*"1+)XW8!B7"]6"BX,LL=%D- *9G:+T2$ES-6 M1_M._"5W4/HPI"D*8%>]ZP)*'TNBA74Y@&)Y;,KJ M+,IADD)8Z7 >H MLH4& (6%#4K>4!5P1K!,-CJA&F,"F8W[+%@H%1'K<4VHE%59:EN^WXJ6[[?B MI;OM^*EN^WXJ6[[?BI;OM^*EN^WXJ6[[?BBDYAPM&L@G"I0^)&5 -< ]O*.7 M1HYG!P>TV6>L2JA*!"%#(B7$:N0-E[WIL-863D^*>--:2@I!.R@L-JA_LH18 MJ(!H90.Q+K..DX * 2RDY*A2,/]E(?[*<&4+C]!:@HAHA_LHJW#_;^@(@PH M@CH*I ,(R,L;$C!I(P_V4A_LI,$.2+E(A0 $@%%".19E2J :PB2H#FJF46N[ MM75:U:\*][US@0$!K9.GXQ#[#!(]-&D K00KI+@ <"MZ4@1O,A:ET'H$62*! M[-3&+B7$$D98BQP-&R40 Z+JQ 3W+BH?[*0_V4B@35YRD["40"4V MZ-V&9Z MP!+4]0KL8VX&)+25#_92'^RAA%8Z5"K'+"*YXAD6S$^M+!:WPM*D%"!"AA$2 M1&N_XKO^* ;VD44P,$F%WZ'FFO-->::4C=O=/&$[,N6!87XBP&2D/]E(?[*0 M_P!E(?[*0_V4A_LI#_92'^RD/]E)B3,!&X;DF1P*WQCA\@6>+$581&EA0(P; MEBD5RM=_Q7?\5OV38QF^?5$I0 \7^IHCP9>W-VN^I;];P&&A70FZHZW*H:3S MCLE T *[Z[Z[Z<[CV?24FRPC D%'*X8 6]4 W<"W9 ]]=]687UA<[$CI$85X MD:7C6RY^ ((2!D0:'49AH02C3).CAZ7B]!BH0#8PQ-5SC@F?<0?XQD >99\N MNF8])="8V4H]4J&8"6"D_JR()VZX[&!95Q3\@5WUWUP+4?%)+J6R MB>^N^H-O2MJDE%7"PQP07@3WBZ!",,>(72F[N\$_W-,?FFO--"O#E5 -9CD1 M*AXNJ0NO6.$:J <\+*H@!%NA[()'5TT7M:DJD EI,&VE/5+@,-1U[Z[Z[Z4 MINWOXT8'?UG@IPF\C(!WUWT4Z>F*4F6HF* >#?OWQN*I1NA_]=0 KWUWT $= MDNJ@3'0DJ)'0=*PU#%1=_*#1%6=G$R6\13"C31>UJ0J01&3JOHR!BA&4*VS' M8OZAGDW&\L37FFO--+ZM^GK.@8E)+E\7ROH'#>E?G=FO,:DY$;E4N( "9LE# M$=306\DBLID95$@QYC7F-0>J>M.8T^1"R] 4+,##C4 =&GYPIW8RY$+!1* M>8UYC0U&; PR S[(K:82H@[>,MX:)<*6P45I!JD08$A=;5$A4\3M FB@IB!T M=I*$B MAIBP=AP<]-%R'F->8T+^VT9.V% EXSN9()I)-93@<3 %T@6%VP;\2C'\AKR& MO(:SB"&E=X4D6M(;X%(#'58291E6CBJ3X%+,#,D!(HVJKIV[0>!1+1$04^9P M98[Q!R3XM)TYJYJYJK0AEDJ7RUYC7F--D'[4 MF$*N9-2?!GPG#B@-S8UYC2U(SPPXU B E1Z3$!!K98D$X&.B:Z-[GY MTH"PJ^0T).*1W*-W*%6Z36CK24LY4PL(A@ )Y(6D,Z89+;JSFD/S +G "Q#- M>0UY#3-<^I1R*7D%4D " L >)'3(C1@LJ=H@R9J._S^*CO\_BFA[41 M,=JEAZ'4D<8@L<(@0( 9 -([_/XJ._S^*:%BK<&@0[RDH7^BMB&B+I4)0<2R M))DCO\_BH[_/XHD LPBWA$465 OT*#AP)ID\P8T4BP1NQ-VKRA4AD&TE3P%X MND845WEJ%:$)A"09+$Q@9*_8N(7$4X9>F6,3MJ>*6IO4- -@:!==H60J -AC M;_\ 5FF.#"2V'U6%C.X,$#*XP^8OYJ._S^*CO\_BCFN[V;^/ \2OXLBBH=L& MF1W^?Q4=_G\5!!QR>(F7W&F*B<50JB0#(!M!'P0J9A6. 0[C!I4@ ,XP!35A MBLMVKLSB:"O+@D75M-0!=?.'H"Y GB F;&0JPH32H031+=8[_/XJ._S^*CO M\_BG)W?W?Q%M!FF$O2CE]TXE*A!ZE2JW)T$"U"CG1MUG#AS> M4_S2%623=>84.2624QM5XIP@C 08R_'8!>< MENAOL!# BU/?!SC!(12_5\86@UU?(?7(_) 2H15!B^><4)X7'F\)@J %MU*E M5)#I3*1T3"IE/ -F2Z\V425A(:@@J2UW19&8B'0J5?Y:N\/%; 'U+0( 4 2 MJM@"H5H\4@(6-L924!04&%L6XJ@B2&"QU=2Y)4,53U"(C3B=+/05RXLPF)%- M5178(B4# QSQ'3"0%*:$^14A::^(2B8*DP@RTFUS$HP>+RVUJEY)#)H@D#$0 M"G@,.4R14 )@ L ()"FZJOA*E2LN/^=ZPN%<##?Q07(PW;#-3(*$'0J53RHO MRO 4=V8>(6D+MDZ5P;V(#J*E1'C@Y6RE!!!>-!P)8!D0;SQ0 +#B)D=;'6(@ M;A%,_47\!",23!289!XXFH85.'!5<6@K&86FXTB!!9*"ED3%DE?3B1)-$,4] M1%:ZHDGZ4-%"M;K48=& E7+^X39R7T9CQ7(*NP6F^V $B!UB_*PJ&B^,(2.H MAH*EYG_FZ-N,KF .V;@D5+BQCLN%YD&85< 51:J!PC4L,H8E%;I_P T++"1 M#&H2%#L"&CIUL($PI:8 ML[MVH?0E1"TNA,WT"):;*IMU(D5^,$MV]Z-Z,BE,KP2(#G!91,[^0)/,30U*:FFHWIODT:GYL"$P:DA@EBV;>)L6")FENWK77"KI9/".G.,-12BBN6G"1B^\@P&SX'MZ**\(Q[ +=6D)W (*$DFN$F A*@@0OTW4#*T#:OVK*XDI+&1_8) M,,@0),VV0V5:BHR(-=6+(H1Q4_"=)DFSKA%P* MYO0]=F<$E&XUD$10F.+#2(;4A=ELT>'8+640,2B^E&158\6&3"GE$1$ M'9>[ DIJT"'-B^+$8 2*WJR2P=L-2)I5N% I!H9T96,;S-C,("VO!D+PM\ D MW!D@;EVW#^JGK-AMCT5&:.+\'"+1FKA&FN)&GU"YK1H3HOYG^4>"@D0J]&," M(:7 DLS= D(@;-C'7T4, $'9%R/V#RB#Z$8'4EE$)J4ZV!9(>-0&;TWQL,KQ M$$JGI&\UW_2\LVY''!8 /,S*=X6KD.X Q;)E>L.^T9UE 328'+BI6*5BM>)ZAB\X$2@3$ $ 0 M"Q^Q>420DC*7BP1.A(+!3\HS% TP%6<)2V*FU6C*_P!=O%TC>:[_ */EGRA_ M<%"YVM*JJJJJK*K=5;JM#]9!VV"7$RI?JNTL@%;FJHFDY"U)@-N1B IV+AYI MJ!3! 6C.]1OX.$;AR-'&LU!H@&#AQ!O:@"91N(; I"E\Q&6;5$,MSVUT:?F+-1PUDZ[.1,-)BAJ_*-<$ ML(6"IH9(5N1-E,34FDD(NSM/F*W45=[ Y;>)C7%1)$#EP@/W(B$,XF7$N6!$ M8Y.1_4.4B)$9T#1:);SI39LFGPVQHR+S2<+$0M3+Y,M@7\5GPTOS'J!;WM3* M:DZ?""3-E0FM0LF4/.X)-; I>X'D5JJM0A1,APQ&R=[A^DG M%< 1+%G-AF$,4D](2G+2'D[Q>]K(S1;(BPQ-7W_9?-E!JSR,D9G.M+!TH7 C M9M;"-3D[9O\ -UG!X(WFN_Z/EFZH9JX3@:+#S4B1_<(<)6 )N M@Z_HK&, AQ"'%8 X:NUL%6]2IV7:*>%*-&C>96OEZM S1RQUC M1IRCS)!CL7IPC%1F%B0S729N$%!0U+Q)5(RC*8(R"4:-"4Y< (3%W96T;BH- MM#GJQ"R;+HG-P"%BE)%X5;@/Q5Y37]%41WQ.EX?.F MQ?T6B[3Q?_\ E6X#\5>4^#_^=,(/QY=IT_H60^_JN1%]GOPWK1&M7^G=UMSI M?).E6FO$1']5%>:V=Y"/=/!_]H " $" P$_$/\ A,(6LA!WK\(4'F6@-%?Y MA7"]JX'M7^84IHI?$E#_ &%#Q#YYK#D_XYN"M,NX[5H,O-8Q];-D/%J8SGO3 M<%/^)N 1N:NESXH (,=5"ZP5JD]J=,M.F%+;>U><']5YD5YP4;GP4#LT:XHU MEY]J&S)Z?U6"'5!LXJXW/BLH=Q_PN!6WJ^-^K-PHF*UJD'%*MUE^L9!*U23F MOPU8-AYM5GM5Q\CBD[+;Z?\ HP2UK@[:?FL6,4H7<5:;GG6K>,'%9S^ER9* M+8R47$^C1N[M2*AL_OUS;;_ZH*!2@EL4"PE^*SC]7@&=C4;U'\_W5Y;[_P![ MS8K^K_O^JL&Q5DN?BFI<_K[67V.*%ZQV_K?[U#^\(P2U>5_M[5;B],FMM^Q\ MC^[ZX*%X_P FK79\O^;=P6-]JWKU6E5*E_YG-C-#"IJ>$["=);Z4.3\+^Z]( M F]DOQ30)R@]Y CGP@K!FIBRYDQW@J;%S,N/:D:CN(<^].-:HK9LA^E_S=@0 M6H)G)/:;S.$K_$H)0G,(CD?*YDDDL\V?Q7FS^* M7Q40 E%( "5VHT Q'()N<&&PZ4)D^/?-(L;J\#RB<$MJRM6JEPAWXP<(R% M M!5WD]0J.U1VJ.U1VH8TN/RCO"CXVJ 'S1W5:^HW$M3:@O*%P5S87-(X=G4/"$(X@[$A#NN^W?P75H2VG,=@7N>O@ PV1'D6)^I?UI!'7@*-9>X76DU M0S"(4(W"V$ ! !8 + %@,=2\1&59$P=IVF _H"5FAQ(1(.71!OX*:.N\EJJ5 M:HKO4N:ES4N:ES4N:ES1J6Y2*C[+UI5*2OI #8B;3WL9%I14P4,SU#D0'LG; M;JK()LJ '=0J+" \Q2>42[JO@$&^_P! TCDF39!HYX<[*#T1$FPLN3<.(,$ MD@LBL]9)$TN+2H[" !+FIHPGHU%"*ER<&7@$;+C/@BU#W<4%V3/?45E=88[X^S[5%13O1!'WG, MKZLF*BAT912 ;5=5T!*E@5L-1\ LH3$_&@RC(Q-144.\,&[R/&X:B]L"BJRW M7QCQ$ 9DM):;$9Y+BI MSL$5]5/@*G&T4_9'Y'M2!K@=>@4Q_K3#J42&RNN-[0](.:@YJ#FIA,D+ %6F M)Y*%@VC&]Y'LE-(VPPGER0H)>6Q4VOCR']C(C"A$$2H.:@YJ7F4!:(DY:/6Y M;]"$3WR@>L[ HW(J*@H'^9;]AC$FM145#R-L+A=U7MW\(49NV2P=(;6;V"(5 M"BSQ:#D5TF""202$L@L31?HC('M.-W6:)[6/E?-"#5Z^YCO?G[>:A4*%\H@7LX9_@L25"L# U:,6<].Z/ M="07@F78%H&(.[&#T J%&]F&Z1M[PKTY*A4*L;'JT#/[/3P(3((C=K8(Z@EB MXD5(3>2N1 XY*TP-G9 >BEZE)10*),J 0N@ 6'XM,*A1#IRUM0R76]NEA-2P MD50J%023I]X[&9.T+"P6Z..U70- @%@!8/H$+ )%P[GIPF+YEU&)#T3##EVL ML3$@2 V>Q!C28I;%UNE*_5#@;9 73%V6&!:74] G)1^%O>R-<^ITCK9]LE3A M8\TA4*-O+3$/<@G^U0J%7 IGVR7L(VG&6? "4'L,FV[/>][]29"'.D"0W6%U M@:'U;*Z]O,B./OXJ:FI509G4\2^H+@O&*FIJ/<3; 9P/773/J4:8)] \UFG MU%$< 2KV":D9%J6)(C%D&Q8J:FC)F6OO5=50[$=C*@.6#6BY+%%@U=T MRBZ*55J2<,H082#,EH$4%*-F/<7D++(4.0M3,3+4227V$D- E#6CH1"(1H0M MP6EB#P"YJ:=-H,MY6,Q[V3L"2+4 !8J:?HEV@:!E2 70 J5*M/GVFL;/>% MA8'CMG@-(E#PPZ2U+4BZVJ1"A2P.@3=SV& ^C+O4N]2[^#Q+S*D6L).ZR-P= MFI=ZEWI2+B=S[=8Z K!=:F@#SR\T)J&&);PU"2"P34->@(\-/2#!,(DB=RIH M.R9]@A/H'H4_!0B-D2R)N/@;0F0;,"\H'LB62I:EI IY2^6<%@D8PH1)41CV M 6&RGE"<_4MOOIS-B.-<7G6+6JU;CF%H,7@0]HXJU6K,!;I=3RD../2THE'> M;V%2U2-A+\2KW28B]M,AG-[AP2OI)[U:K5#/M =U/K]G6$-[&9:>(*2_D"9D MX>H==8)^[N[SVM>=:C3!F^H+-+W-?3PB[5:E5@W8,G8,JV 5L48 W(88TW=L M%8< JU6H&D8458+.2-(6X^B!#3$.SZ"81O$QK5JM4HP5J1*<@)S'U_ ;,)D, M "J[!0'20B-]$F4E0LJ!#.E_L&#J2$V7FZXP]+93;&0/#'>*M5JEE$4W,1'< MD[K:E QE+\HN]RS*6JU6O#YL!Q"\> !&7EM$"YJ V(5Q&U6JU9R235N$H300 MC<1J3!7)>P2O[QFE TMU0[H /I.U4:QF)_&F.)UJ*BEW!"+)=MLWJ(^"QI## MTF/O44)B0^\?#%6F60H% 2L%&<",M8E>JO6HHK5"N6R[(6-B[3&'6I%15H") M;5D1O!CW>>KEBLNB"]%\T@*&MP0]12A29(8C7#AP=X;E C(F+.70%@Q-BZB5 M#B6#()L$IRK2_J#G573A,DB#<\,N*BHJ*BHJZ>8 SCZF[NQ&_1MG>*\$/M+[ MU%11/PEV!Z[BWKI]**BHH'D% $5<$);"KS4>^V9[PGV1YJ3+B%RYJ2B.J'H% M144W12& "55L 75P5+5A ;7W'=+I((Z,)P*Y8+N'R:BHJY8.VBF[VOIA:L"Y M1[Y[#Z145D48X678 G(#0D.&PVK#YUM,Y+0D MP\N/9ZGV4!1!D1+B-Q+C0&\&$1.A A#);KE(Z=;V1 N"B@D%UA\&0MB6%=[L M"I86:.Y\C6+LS;&1G#'Z$N!]DL"4$KNH!JM3-S'0@HK) *#9%&I!39.L'1@)72!>BT,L!Y7ID0"P8,O!6V51"D.),&P=&(E"TF!S 2C2TG MECJ\G 6K&!V'8ICQ)81 <;:XP: 0M!1X=IS;#6;05:AM0$D9&IJ:FKR]!"\Q M49".S(3\J?6YYZZQ04HY9K#XB\P'*EW./7MMA$6,+V;LNR=,%"#ZVT M-X'8EL/3*,<[_P 9=?/] [KX^[J#263F%J;+:)J2@2F!L #: 73 *+"M ?$P MW$1A %!"/R(MG2$(AJ%$,( LCU0+OM"$PA,PO6BNQ;%$I;(4<]!)=3Y]P%58 M +JK8 NKBI:A]MHI$/4%PE0NC T2,X)M4!6[*$GKF0HP\F/@"'5V&I5*H^R:NBP]1/13#F&RM1R(C]'TUZ:]-"=RC1(32PVD4=%I H0 MFSOH#7L7: 5TTG/-K4Z7+2/>V$Y"EWQ%H2L]G>Y.:BHJ-L+Z*/<\12$0AKS;BHJ*/DS9!)>XY9VE1.91BU&:SBHI_&#DD8 6T11A%&STLSFNQ-F8"6PQQ1JQ'< M& X1&HJ*>PTH"WI(+QG, \<"XW]5U'.,D[H?2RSUU\>%RQ&"#;BUNA@ IYB"3+-K1-[;]M]:)3@Y . M%O94E24BP2[A1[H]:EZ4*K=5NJ[KTG#ALMPOE)XJ2I*D0R5]QZ)].B9V3X[V M^*'FAI0Q7$#V#T4Q5@LH1/ < MJ!$GVP0FR&$1:\)L@3+L)=Q4+ZUZUZU,_P#^_$?%( %=8^@B=B*2%,3CDWN. M)QI6BYZAGF:[U!=R>^L+:(>!ZR5)4GC0>VQ$$KP++Q18PEV('H 5)4E1A<_, MWL_ ?!Z.03EN)735O4E24#0!$;B-D342I/KG993ZAZG2..)'K.!VD7KPE>M7 M6%9(=D)Z)405XS$8%^;YJ"N,VS30$6Q$9W9 D,#$V .Q7K7K1@R4T0(W)$W M%VB6LW<^*=XBZ7+)?B]^HHJ#@[9ZS#P]4B2 N(Y^]KZ-AVEAO.,/ M6%B7V%OA>KCL)Y"9B.A 2S\ )/<848()"IX;!,CJ4W5DN)2T>,C(PL"*F E]_*@()-T;Y".$N:@:P BQR)1]05EA0!1A=DLW9+H@Q(TBHP0N.B M95<+C2*=@.!<;AA.K3K MJ$ 'A#T ;_BE5+FH64A+3;FCM,#+H!'BNP"9V^LA"UBH5"H5"H5"C()ULS'' M!7I]0 DR3_2&+O9\]4F))X2%CL[T\)]% B61+B.XU%K((P,'H/H=;)4KYPE[ MF)S.,, K!=:@]NR1"$M6R*+2VJ%0J%0J%0IT%A:+:6W\P"X6$Z@6T:*F]F4N MBL$!XD4V'+%+K7"+VZ@ $E0#PEP7N@;*/57A3MR$ 22H@3<4UZNG3PQS Q(A M22I9N 8#J\,^(!2A;7+7MOU 1AN$!<"[*&VW5H-094#5D,%A]!6QA;2X]F/ ML;=W-#A"FIOJ)3LE+4EH=^Q!R(C$T 68,ICB!*;"W"F4D!*I,J5UF\S,WJ/A M$$3HT<14+@#2"OK%NLAR5G"2"!):KF"2N 4(4$-C(I<[."@86UEEZ@ $>J-Y M#"^(6W\"2C@,*)$=$21WHM 1\H $D%>-)B\3U +1PQ$H!%TUPUND/72'H> M =10(C")<1+B.&CP]$*9PBO:FU%H.S(M5D!K86E\U$#70'R!ZPZ8Y0[?YZ@N M-._,H/N_MZ UL/(A[WTK[M[^$ "T7'(,![3XGL2#1"UBB'2SGJ !8(F&$$ MX"G9XH<7AB"0NF4F(&W4 !QKD80(1>$>A..G8"U>UP-?Y+1 =U1#T-^[;FB! M2=]'>?PFA0A34GU$IV2IP2&!!C2R"=)0YH!NC$>LA,Z0K9AM7:IL.I"&=Q- MWI+92H[="KW?W!&"6LP?+'-3IQH?\W?\;Z"?_K4Z<:'_ #2,"6CU#MI5^9T/ M^:$ J"[2KV&VM&P8*U ^WO2,DOZM90J@YJ#_ %2W^J;FC[TO'0!8]&:" 6 M%.8M-Z]!X7WJ5-D?"C)#1MK7>D4H)2]0T#(?BL&3]5ARUI@*O3=YH (,= M+7G92>S;]=\9]J^9U,5\Y]Z^85\SP_&?:O,[>"'W;M3PX,_3>EU9KWQ0B28Z M9,4C)/F@9#627W^U1%G]#D!I>8//%:H]*P ];UC'4ZZ]6NWY?L'QGVKYG1X] M&:!%@I9*Y6OF%?,\/QGVKS.W4P[DZ3.Y^J]?2+"'9VZ_*/T(E*AJV6/FLTP\T(DE MS])E043&>]9]@X_9/C/M14D32V52JRW>OS"OF>'XS[5YG;JH-C6;U)W[/\ &?:OF>'YA7S/#\9]J\SM MX+D_!3#2?)^F%,4#A4!K/H4:AY>M;PJ?^OQ4_P#7XITA[TZ0?-+;'I2V5]J< M@O[7\9]J^9X?F% 6(KF>UW3XS[4"SB:YGM7,]J&,S>M0%%[MJN#;< M4O0HUA2ZRL/^(X!&]7EEVGALOR3_ !7DO7DO7DO7DOTX!&]>2]>2]>2]=X-) M_GH3.4U:PCG/Q_-$Q?-<">:ML1V?F_MX/__: @! P,!/Q#_ (1&2%)N"N"N*NY3I+2]&DMFD]Z(KP!>720GB)\*@4 % MVH'+HOT1,2)B2>Y0HCX7R,Q(FE41RM$XF%%6QN6+?%TE]-_TL&Y_N='S4BB> MA8'*.N^9,B%06HWN7#9AM0(=D)#<"B=GZ-DP1%R00C,*? 1HT:XT^ MQWXV034HAM9EIDM@QX(TTLMU$U&1&Z$!$\(D# M49F[)+.[+,SX(T:,1!H.!YRWAMQ/&M,DAH_>B[DIDC=JG?-"!][@Q(2A([TU MS47.[#WJ_-7YJ_-7@C*R/80(L@1+)%!G+X7UV*20J220^.ZP9S+$,YR[#5^? M8J_/L5?GV*OS[%2^2%S%$B<'%B4&'P*]D,-80G+";/L7Y]BK\^Q5^?8J_/L4 MA2$]J[ZDO7ZLF_/L5?GV*GJ>EU4*$61;"0D1$$10-E)%$)!*$JJJJRMVK\^Q M5^?8JQ9*@DJ(.KC=+T_0H#,++=)-Q9)6&[P>X^6TRA8G& )4)5KVKVKVKVKV MKVH#$P',C/L/I4","0!8 P!H'2?,U/F:GS-3YFI\S4^9J?,U/F:.7>\-GLTO M @$M6O%<<$"UA0W!,(/4]:6X0=P"O:IA(HLR)'!0, 6J_/L5?GV*OS[%3FP M#B69)I8,(HB-<0"< MP!D,X/ \U7PLB86B*^VI?,5 #&:@Z*1).Y).TF]2^8J7S% ^9?.\>+MH2\7& MT0OU-LOF*E\Q3;W27L/?0,!E4#NP*"M9Y$"V/204@$;+"7S%2^8HS,-!6A"# M:PT90(M0 +'C>0\R412B7E:4HT R1*Y5JN@$ 0 $NY4NY05FEG$T38EP M)-09)4O9AF=IU?S509/E2'84#R\&H,2&$!.D'D-A3O497W4SS\;9S5HS])7$I)-=WN@ J6REQ( M.AKW-1$!*A%"RXJ7%,6GFRSC@/+$ L =%S$JW+.4>)3.S+YBI?,5.8 #$=]M M4G(DM4OF*E\Q6;I6RVWB5!HZ2,>%>T-V!%(:SRM[*)3+N5+N4^8"+*I 8LH2 M**2F0TZ0[\2>&Q=%T3!V)6CL00J@!6*YPT,9URCEJ:BR)5&4I;$\!.82IJ:VC+Y0/ $H8-C8 M?(^+@X*TGAYX,9F!Z7I(QV!R#'"])J:<;#0O%CV0+0GI4U-6>2DN5 &DJ&;TP1X%_*7OA" M7= &EK6BIJ:(2%C1&N8PH) NGZEY)M$8NT\VQI+?K4&2I&JS;%A;@"2_6DGH M:651Y!O87#T2,"D[*<=T)TG#$-$K !D "A% UDH[(;UD'5=Y5&81AHMB8, MF:@9"#DR59D%B/!+(O3,&Y!$U.42;=R%EU$EGKM0-%22QIW%E#FD&YD HU M;*MU7*NJ](2@82ZNJMA%\+ "U9D8!#'=)N=JLOH1$>D?8%3-@XJ M8^A0&11(CJ)X/;4:/'3 M&8#?,0I)M&K"&Q@5V4AZGL5&HT44O,[Q(CC[N.JUI(QR#1%QUUDYFP."6,0S M[)$29FW71H"(N=F;DR;B1H49ZP$:U?K:UI$^ (=#&HT(M;]'F#58"Z NE+FY M!D:F(6,H"9$NHU&B2<4(HB$P@+RP@/T:L:3))<;'*"MIB;Q4:C4M/TP%9P;@ MMSZ4>:CS4>>NUQT2BKJP#54*BO9R,J3*Y 8A( ,>:CS4WTS)I J,C0P"8F"=U M5F8X6D3@25; &5=J9I99R-GH/I=.:UYLP$.X.<0)D06"87^]GV?9ZXLM.?07 MXTEL8O9.G4)"L909V9<;Z6V9FB>F TM1&1E/T!+O<61I@DXMF(KHS%X9T*0F M2@9#=FZ!K$!@HB0*R+$)BS+0JM3P!)>,?[:K"070*X,E8@W%]%;K)AL@7U/8 MZ\%DEVU?265SMK]7S*J]!K!C N@<*1*6XFR$A[#BHT,N)#"&V S&5+/3'RY;#4?/^5'S M_E%4@E[2,;7D@;HZ?2[%=BNQ78KL5V*[%2G./;@)L95@$J@+05N243-5T"UR M_*(](10EP\13,Y1+-9I%RZ5EUP' UN BU&;PB]*38&3R5'S M_E1\_P"5'S_E3)3,5H;C9.0$DT/C*?7+]L[%IP%0J%.FI1

XML 12 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Related Party Transactions
12 Months Ended

Dec. 31, 2019

Related Party Transactions [Abstract]

Related Party Transactions
NOTE 4 – Related Party Transactions

Related Parties Loans

Qiuping Lu, President, CEO, director and shareholder of the Company, advanced funds to the Company for working capital purposes. These working capital advances are payable on demand. As of December 31, 2019 and 2018, these working capital advances amounted to $272,814 and $238,022, respectively, are reflected as related party loans on the accompanying balance sheets.

During the years ended December 31, 2019 and 2018, in connection with these related party loans, the Company imputed interest of $20,372 and $17,908, respectively, and recorded interest expense and an increase in additional paid-in capital.

During the year ended December 31, 2019, the Company sold 5,000,000 shares of common stock for $5,000. This was purchased by a related party. As the Company did not have a bank account, the funds were deposited directly to Ms. Lu's personal bank account and was accounted for as a repayment for advances outstanding made by Ms. Lu.

Office Space from Related Party

The Company uses office space of a related party, free of rent, which is considered immaterial.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 13 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Organization (Details) - USD ($)
12 Months Ended

Jun. 27, 2012

Dec. 31, 2019

Organization (Textual)

Sellers sold to purchasers an aggregate shares of common stock 4,000,000

Percentage of company common stock issued and outstanding 93.00%

Total purchase price $ 159,970 $ 5,000

X

- References
No definition available.
+ Details

Name: TJBH_OrganizationTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of Company's common stock issued and outstanding
+ References
No definition available.
+ Details

Name: TJBH_PercentageOfCompanysCommonStockIssuedAndOutstandingNet

Namespace Prefix: TJBH_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 35 186 1 false 9 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://chinaherb.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://chinaherb.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://chinaherb.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations Sheet http://chinaherb.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes in Stockholders' Deficit Sheet http://chinaherb.com/role/StatementsOfChangesInStockholdersDeficit Statements of Changes in Stockholders' Deficit Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows Sheet http://chinaherb.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Organization Sheet http://chinaherb.com/role/Organization Organization Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://chinaherb.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://chinaherb.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Related Party Transactions Sheet http://chinaherb.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 00000011 - Disclosure - Stockholders' Deficit Sheet http://chinaherb.com/role/StockholdersDeficit Stockholders' Deficit Notes 11 false false R12.htm 00000012 - Disclosure - Income Taxes Sheet http://chinaherb.com/role/IncomeTaxes Income Taxes Notes 12 false false R13.htm 00000013 - Disclosure - Commitments and Contingencies Sheet http://chinaherb.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - Subsequent Event Sheet http://chinaherb.com/role/SubsequentEvent Subsequent Event Notes 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://chinaherb.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://chinaherb.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Income Taxes (Tables) Sheet http://chinaherb.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://chinaherb.com/role/IncomeTaxes 17 false false R18.htm 00000018 - Disclosure - Organization (Details) Sheet http://chinaherb.com/role/OrganizationDetails Organization (Details) Details http://chinaherb.com/role/Organization 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesTables 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://chinaherb.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Going Concern (Details) Sheet http://chinaherb.com/role/GoingConcernDetails Going Concern (Details) Details http://chinaherb.com/role/GoingConcern 21 false false R22.htm 00000022 - Disclosure - Related Party Transactions (Details) Sheet http://chinaherb.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://chinaherb.com/role/RelatedPartyTransactions 22 false false R23.htm 00000023 - Disclosure - Stockholders' Deficit (Details) Sheet http://chinaherb.com/role/StockholdersDeficitDetails Stockholders' Deficit (Details) Details http://chinaherb.com/role/StockholdersDeficit 23 false false R24.htm 00000024 - Disclosure - Income Taxes (Details) Sheet http://chinaherb.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://chinaherb.com/role/IncomeTaxesTables 24 false false R25.htm 00000025 - Disclosure - Income Taxes (Details 1) Sheet http://chinaherb.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://chinaherb.com/role/IncomeTaxesTables 25 false false R26.htm 00000026 - Disclosure - Income Taxes (Details Textual) Sheet http://chinaherb.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://chinaherb.com/role/IncomeTaxesTables 26 false false R27.htm 00000027 - Disclosure - Subsequent Event (Details) Sheet http://chinaherb.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://chinaherb.com/role/SubsequentEvent 27 false false All Reports Book All Reports tjbh-20191231.xml tjbh-20191231.xsd tjbh-20191231_cal.xml tjbh-20191231_def.xml tjbh-20191231_lab.xml tjbh-20191231_pre.xml http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 15 0001213900-20-005061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-20-005061-xbrl.zip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end XML 16 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Income Taxes (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Income Taxes (Textual)

Effective tax rate 21.00% 21.00%

Net operating loss carryforward $ 419,496

Increase in allowance $ 8,293

Operating loss carryforwards,expiration date Dec. 31, 2039

X

- References
No definition available.
+ Details

Name: TJBH_IncomeTaxesTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwardsExpirationDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 30
-Paragraph 5
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109238119&loc=d3e30536-109315

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_OperatingLossCarryforwardsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 17 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Related Party Transactions (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Related Party Transactions (Textual)

Imputed interest $ 20,372 $ 17,908

Common stock 5,000,000

Common stock amount $ 5,000

Shareholder [Member]

Related Party Transactions (Textual)

Working capital advances $ 272,814 $ 238,022

X

- Definition
Common stock sale.
+ References
No definition available.
+ Details

Name: TJBH_CommonStockSale

Namespace Prefix: TJBH_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: TJBH_RelatedPartyTransactionsTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The value represents working capital advance from related parties.
+ References
No definition available.
+ Details

Name: TJBH_WorkingCapitalAdvance

Namespace Prefix: TJBH_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of other increase (decrease) in additional paid in capital (APIC).
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_DividendsCommonStockCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: srt_TitleOfIndividualAxis=TJBH_DirectorAndShareholderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Balance Sheets - USD ($)

Dec. 31, 2019

Dec. 31, 2018

CURRENT ASSETS:

Cash and cash equivalents

Prepaid expenses 4,299 4,000

TOTAL CURRENT ASSETS 4,299 4,000

TOTAL ASSETS 4,299 4,000

CURRENT LIABILITIES:

Accounts payable and accrued liabilities 11,125 11,125

Related party loans 272,814 238,022

TOTAL CURRENT LIABILITIES 283,939 249,147

STOCKHOLDERS' DEFICIT:

Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)

Common stock ($.001 par value; 70,000,000 shares authorized; 43,136,540 and 38,136,540 shares issued and outstanding at December 31, 2019 and 2018, respectively) 43,137 38,137

Additional paid-in capital 201,095 180,723

Accumulated deficit (523,872) (464,007)

TOTAL STOCKHOLDERS' DEFICIT (279,640) (245,147)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 4,299 $ 4,000

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Statements of Cash Flows - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss $ (59,865) $ (47,806)

Adjustments to reconcile net loss to net cash used in operating activities:

Imputed interest on related party loans 20,372 17,908

Changes in operating assets and liabilities:

Increase in prepaid expenses (299) (667)

Increase in accounts payable and accrued liabilities 125

NET CASH USED IN OPERATING ACTIVITIES (39,792) (30,440)

CASH FLOWS FROM FINANCING ACTIVITIES:

Refund for advance for future common stock subscriptions (2,937)

Proceeds received from loans from officer 39,792 33,377

Proceeds from sale of common stock 5,000

Repayment made for loans from officer (5,000)

NET CASH PROVIDED BY FINANCING ACTIVITIES 39,792 30,440

NET INCREASE IN CASH

Cash, beginning of year

Cash, end of year

SUPPLEMENTAL DISCLOSURES:

Interest paid

Income taxes paid

X

- Definition
The value represent imputed interest on related parties loans.
+ References
No definition available.
+ Details

Name: TJBH_ImputedInterestOnRelatedPartiesLoans

Namespace Prefix: TJBH_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: TJBH_Refundforadvanceforfuturecommonstocksubscription

Namespace Prefix: TJBH_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 20 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 21 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Subsequent Event (Details) - Investor [Member]
1 Months Ended

Jan. 22, 2020

USD ($)

Investor

$ / shares

shares

Aug. 28, 2019

$ / shares

Subsequent Event (Textual)

Purchase price per share $ 0.001

Subsequent Event [Member]

Subsequent Event (Textual)

Number of sold shares of common stock | shares 80,040

Purchase price per share $ 0.03

Proceeds received from sale of common stock | $ $ 2,405

Number of investors | Investor 7

X

- References
No definition available.
+ Details

Name: TJBH_NumberOfInvestors

Namespace Prefix: TJBH_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: TJBH_SubsequentEventTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cash received on stock transaction after deduction of issuance costs.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockConsiderationReceivedOnTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stockholders' Deficit (Details) - USD ($)
1 Months Ended 12 Months Ended

Jun. 27, 2012

Aug. 28, 2019

Dec. 31, 2019

Dec. 31, 2018

Stockholders' Deficit (Textual)

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, shares authorized 70,000,000 70,000,000

Common stock, par value $ 0.001 $ 0.001

Common stock, shares issued 43,136,540 38,136,540

Common stock, shares outstanding 43,136,540 38,136,540

Common stock sold to several investors 4,000,000

Proceeds of common stock $ 5,000

Investors [Member]

Stockholders' Deficit (Textual)

Common stock sold to several investors 5,000,000

Common stock at purchase price per share $ 0.001

Proceeds of common stock $ 5,000

X

- References
No definition available.
+ Details

Name: TJBH_StockholdersEquityDeficitTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 23 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Balance Sheets (Parenthetical) - $ / shares

Dec. 31, 2019

Dec. 31, 2018

Statement of Financial Position [Abstract]

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value $ 0.001 $ 0.001

Common stock, shares authorized 70,000,000 70,000,000

Common stock, shares issued 43,136,540 38,136,540

Common stock, shares outstanding 43,136,540 38,136,540

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Organization
12 Months Ended

Dec. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization
NOTE 1 – Organization

China Herb Group Holdings Corporation (the "Company") was incorporated under the name "Island Radio, Inc" under the laws of the State of Nevada on June 28, 2010. On December 9, 2019, the Company changed its corporate name to Tengjun Biotechnology Corp.

On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the "Sellers"), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the "Purchasers"), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the "Change in Control"). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company.

The Company's original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People's Republic of China, the Company's management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company's plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company has extremely limited liquidity. Through December 31, 2019, the Company has no revenues or operation.

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 26 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total Realized Loss

Level 1 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total Realized Loss

Level 2 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total Realized Loss

Level 3 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total Realized Loss

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612
+ Details

Name: us-gaap_FairValueOptionChangesInFairValueGainLoss1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation
Basis of Presentation

The accompanying financial statements for Tengjun Biotechnology Corp. have been prepared in accordance with accounting principles generally accepted In the United States of America and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission.

Use of Estimates
Use of Estimates

The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.

Fair Value of Financial Instruments
Fair Value of Financial Instruments

Accounting Standards Codification ("ASC") 820, "Fair Value Measurements" and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

As of December 31, 2019 and 2018, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

Description Level 1 Level 2 Level 3 Total
Realized
Loss

December 31, 2019 - - - -

December 31, 2018 - - - -

Total - - - -

ASC 825-10 "Financial Instruments", allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

Cash and Cash Equivalents
Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2019 and 2018, the Company had no cash equivalents.

Prepaid Expenses
Prepaid Expenses

Prepaid expenses relate to cash paid in advance for annual listing fee and business license. These amounts are recognized as expense over the related listing and service periods. At December 31, 2019 and 2018, prepaid expenses amounted $4,299 and $4,000, respectively.

Income Taxes
Income Taxes

Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company follows the provisions of Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 740-10 "Uncertainty in Income Taxes" (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of December 31, 2019 and 2018, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.

Loss per Share Calculation
Loss per Share Calculation

Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the years ended December 31, 2019 and 2018, the Company had no dilutive financial instruments issued or outstanding.

Recent Accounting Pronouncements
Recent Accounting Pronouncements

Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

X

- Definition
Prepaid expenses.
+ References
No definition available.
+ Details

Name: TJBH_PrepaidExpensesPolicyTextBlock

Namespace Prefix: TJBH_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13279-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Stockholders' Deficit
12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Stockholders' Deficit
NOTE 5 – Stockholders' Deficit

Preferred Stock

The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share.

As of December 31, 2019 and 2018, the Company had no shares of its preferred stock issued and outstanding.

Common Stock

The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share.

As of December 31, 2019 and 2018, the Company had 43,136,540 and 38,136,540 shares of its common stock issued and outstanding, respectively.



Common Stock Sold for Cash

On August 28, 2019, the Company sold 5,000,000 shares of common stock at a purchase price of $0.001 per share to an investor pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received

proceeds of $5,000.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Income Taxes (Details 1) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Deferred Tax Asset:

Net operating loss carryforward $ 88,094 $ 79,801

Valuation allowance (88,094) (79,801)

Net deferred tax asset

X

- References
No definition available.
+ Details

Name: us-gaap_ComponentsOfDeferredTaxAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Going Concern (Details) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Going Concern (Textual)

Cash

Working capital deficit 279,640

Accumulated deficit (523,872) (464,007)

Stockholders' deficit $ (279,640) $ (245,147) $ (215,249)

X

- Definition
Going concern textual.
+ References
No definition available.
+ Details

Name: TJBH_GoingConcernTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of working capital deficit.
+ References
No definition available.
+ Details

Name: TJBH_WorkingCapitalDeficit

Namespace Prefix: TJBH_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 31 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Going Concern
12 Months Ended

Dec. 31, 2019

Going Concern [Abstract]

Going Concern
NOTE 3 – Going Concern

The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions.

As of December 31, 2019, the Company had $0 in cash and has been funding its working capital needs from loans from related parties. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of December 31, 2019, the Company had a working capital deficit, accumulated deficit and stockholders' deficit of $279,640, $523,872 and $279,640, respectively. These and other factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

X

- References
No definition available.
+ Details

Name: TJBH_GoingConcernAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 40
-URI http://asc.fasb.org/subtopic&trid=51888271
+ Details

Name: us-gaap_SubstantialDoubtAboutGoingConcernTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Document and Entity Information - USD ($)
12 Months Ended

Dec. 31, 2019

Feb. 28, 2020

Jun. 28, 2019

Document and Entity Information [Abstract]

Entity Registrant Name Tengjun Biotechnology Corp.

Entity Central Index Key 0001499785

Amendment Flag false

Current Fiscal Year End Date --12-31

Document Type 10-K

Document Period End Date Dec. 31, 2019

Document Fiscal Year Focus 2019

Document Fiscal Period Focus FY

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Filer Category Non-accelerated Filer

Entity Current Reporting Status Yes

Entity Small Business true

Entity Shell Company true

Entity Emerging Growth Company false

Entity Filer Number 333-169397

Entity Interactive Data Current Yes

Entity Incorporation State Country Code NV

Entity Public Float $ 22,670,675

Entity Common Stock, Shares Outstanding 43,216,580

X

- References
No definition available.
+ Details

Name: TJBH_DocumentAndEntityInformationAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 33 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Statements of Changes in Stockholders' Deficit - USD ($)

Common Stock

Additional Paid-in Capital

Accumulated Deficit

Total

Balance at Dec. 31, 2017 $ 38,137 $ 162,815 $ (416,201) $ (215,249)

Balance, shares at Dec. 31, 2017 38,136,540

Imputed interest 17,908 17,908

Net loss (47,806) (47,806)

Balance at Dec. 31, 2018 $ 38,137 180,723 (464,007) (245,147)

Balance, shares at Dec. 31, 2018 38,136,540

Common stock issued for cash $ 5,000 5,000

Common stock issued for cash,shares 5,000,000

Imputed interest 20,372 20,372

Net loss (59,865) (59,865)

Balance at Dec. 31, 2019 $ 43,137 $ 201,095 $ (523,872) $ (279,640)

Balance, shares at Dec. 31, 2019 43,136,540

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_PaidInKindInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

EXCEL 34 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 35 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Income Taxes (Tables)
12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Schedule of difference between income taxes at the effective statutory rate and the provision for income taxes

Year Ended Year Ended

December 31,
2019 December 31,
2018

Income tax benefit at U.S. statutory rate $ (12,571 ) $ (10,039 )

Non-deductible interest 4,278 3,761

Change in valuation allowance 8,293 6,278

Total provision for income tax $ - $ -

Schedule of net deferred tax asset

Deferred Tax Asset: December 31,
2019 December 31,
2018

Net operating loss carryforward $ 88,094 $ 79,801

Valuation allowance (88,094 ) (79,801 )

Net deferred tax asset $ - $ -

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Commitments and Contingencies
12 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
NOTE 7 – Commitments and Contingencies

At December 31, 2019, there were no legal proceedings against the Company.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of financial instruments current fair values

Description Level 1 Level 2 Level 3 Total
Realized
Loss

December 31, 2019 - - - -

December 31, 2018 - - - -

Total - - - -

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959
+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Income Taxes
12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes
NOTE 6 – Income Taxes

The Company maintains deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets at December 31, 2019 and 2018 consist of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty of the attainment of future taxable income. The provision (benefit) for income taxes for the years ended December 31, 2019 and 2018 were as follows, assuming a 21% effective tax rate. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended December 31, 2019 and 2018 were as follows:

Year Ended Year Ended

December 31,
2019 December 31,
2018

Income tax benefit at U.S. statutory rate $ (12,571 ) $ (10,039 )

Non-deductible interest 4,278 3,761

Change in valuation allowance 8,293 6,278

Total provision for income tax $ - $ -

The Company's approximate net deferred tax asset as of December 31, 2019 and 2018 was as follows:

Deferred Tax Asset: December 31,
2019 December 31,
2018

Net operating loss carryforward $ 88,094 $ 79,801

Valuation allowance (88,094 ) (79,801 )

Net deferred tax asset $ - $ -

The net operating loss carryforward was $419,496 at December 31, 2019. The Company provided a valuation allowance equal to the deferred income tax asset for the years ended December 31, 2019 and 2018 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The increase in the allowance was $8,293 in 2019. The potential tax benefit arising from the loss carryforward will expire in 2039.

Additionally, the future utilization of the net operating loss carryforward to offset future taxable income may be subject to an annual limitation as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.

The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Income Taxes (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Income tax benefit at U.S. statutory rate $ (12,571) $ (10,039)

Non-deductible interest 4,278 3,761

Change in valuation allowance 8,293 6,278

Total provision for income tax

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationNondeductibleExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 41 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies (Details Textual) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Summary of Significant Accounting Policies (Textual)

Cash equivalents

Prepaid expenses $ 4,299 $ 4,000

X

- References
No definition available.
+ Details

Name: TJBH_SummaryOfSignificantAccountingPoliciesTextualAbstract

Namespace Prefix: TJBH_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 42 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Statements of Operations - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Income Statement [Abstract]

Revenues

Operating Expenses:

Accounting fees 11,405 11,050

Other general and administrative 28,088 18,848

Total Operating Expenses 39,493 29,898

Loss from Operations (39,493) (29,898)

Other Expense:

Interest expense - related party (20,372) (17,908)

Total Other Expense (20,372) (17,908)

Net Loss $ (59,865) $ (47,806)

Net loss per common share, basic and diluted $ (0.00) $ (0.00)

Weighted average number of common shares outstanding:

Basic and diluted 39,862,567 38,136,540

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of interest expense incurred on a debt or other obligation to related party.
+ References
No definition available.
+ Details

Name: us-gaap_InterestExpenseRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of selling, general and administrative expense classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherSellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))
-URI http://asc.fasb.org/extlink&oid=116637345&loc=SL114874292-224272

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section 45
-Paragraph 3
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=118262090&loc=SL114874205-224268
+ Details

Name: us-gaap_ProfessionalFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
NOTE 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements for Tengjun Biotechnology Corp. have been prepared in accordance with accounting principles generally accepted In the United States of America and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission.

Use of Estimates

The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.

Fair Value of Financial Instruments

Accounting Standards Codification ("ASC") 820, "Fair Value Measurements" and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

As of December 31, 2019 and 2018, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

Description Level 1 Level 2 Level 3 Total
Realized
Loss

December 31, 2019 - - - -

December 31, 2018 - - - -

Total - - - -

ASC 825-10 "Financial Instruments", allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2019 and 2018, the Company had no cash equivalents.

Prepaid Expenses

Prepaid expenses relate to cash paid in advance for annual listing fee and business license. These amounts are recognized as expense over the related listing and service periods. At December 31, 2019 and 2018, prepaid expenses amounted $4,299 and $4,000, respectively.

Income Taxes

Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company follows the provisions of Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 740-10 "Uncertainty in Income Taxes" (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of December 31, 2019 and 2018, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.

Loss per Share Calculation

Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the years ended December 31, 2019 and 2018, the Company had no dilutive financial instruments issued or outstanding.

Recent Accounting Pronouncements

Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Organization (Details) - USD ($)		12 Months Ended
Organization (Details) - USD ($)	Jun. 27, 2012	Dec. 31, 2019
Organization (Textual)
Sellers sold to purchasers an aggregate shares of common stock	4,000,000
Percentage of company common stock issued and outstanding	93.00%
Total purchase price	$ 159,970	$ 5,000

Income Taxes (Details Textual) - USD ($)	12 Months Ended
Income Taxes (Details Textual) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Taxes (Textual)
Effective tax rate	21.00%	21.00%
Net operating loss carryforward	$ 419,496
Increase in allowance	$ 8,293
Operating loss carryforwards,expiration date	Dec. 31, 2039

Related Party Transactions (Details) - USD ($)	12 Months Ended
Related Party Transactions (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Related Party Transactions (Textual)
Imputed interest	$ 20,372	$ 17,908
Common stock	5,000,000
Common stock amount	$ 5,000
Shareholder [Member]
Related Party Transactions (Textual)
Working capital advances	$ 272,814	$ 238,022

Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash and cash equivalents
Prepaid expenses	4,299	4,000
TOTAL CURRENT ASSETS	4,299	4,000
TOTAL ASSETS	4,299	4,000
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	11,125	11,125
Related party loans	272,814	238,022
TOTAL CURRENT LIABILITIES	283,939	249,147
STOCKHOLDERS' DEFICIT:
Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)
Common stock ($.001 par value; 70,000,000 shares authorized; 43,136,540 and 38,136,540 shares issued and outstanding at December 31, 2019 and 2018, respectively)	43,137	38,137
Additional paid-in capital	201,095	180,723
Accumulated deficit	(523,872)	(464,007)
TOTAL STOCKHOLDERS' DEFICIT	(279,640)	(245,147)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 4,299	$ 4,000

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (59,865)	$ (47,806)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loans	20,372	17,908
Changes in operating assets and liabilities:
Increase in prepaid expenses	(299)	(667)
Increase in accounts payable and accrued liabilities		125
NET CASH USED IN OPERATING ACTIVITIES	(39,792)	(30,440)
CASH FLOWS FROM FINANCING ACTIVITIES:
Refund for advance for future common stock subscriptions		(2,937)
Proceeds received from loans from officer	39,792	33,377
Proceeds from sale of common stock	5,000
Repayment made for loans from officer	(5,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES	39,792	30,440
NET INCREASE IN CASH
Cash, beginning of year
Cash, end of year
SUPPLEMENTAL DISCLOSURES:
Interest paid
Income taxes paid

Subsequent Event (Details) - Investor [Member]	1 Months Ended
Subsequent Event (Details) - Investor [Member]	Jan. 22, 2020 USD ($) Investor $ / shares shares	Aug. 28, 2019 $ / shares
Subsequent Event (Textual)
Purchase price per share		$ 0.001
Subsequent Event [Member]
Subsequent Event (Textual)
Number of sold shares of common stock \| shares	80,040
Purchase price per share	$ 0.03
Proceeds received from sale of common stock \| $	$ 2,405
Number of investors \| Investor	7

Stockholders' Deficit (Details) - USD ($)		1 Months Ended	12 Months Ended
Stockholders' Deficit (Details) - USD ($)	Jun. 27, 2012	Aug. 28, 2019	Dec. 31, 2019	Dec. 31, 2018
Stockholders' Deficit (Textual)
Preferred stock, shares authorized			5,000,000	5,000,000
Preferred stock, par value			$ 0.001	$ 0.001
Preferred stock, shares issued			0	0
Preferred stock, shares outstanding			0	0
Common stock, shares authorized			70,000,000	70,000,000
Common stock, par value			$ 0.001	$ 0.001
Common stock, shares issued			43,136,540	38,136,540
Common stock, shares outstanding			43,136,540	38,136,540
Common stock sold to several investors	4,000,000
Proceeds of common stock			$ 5,000
Investors [Member]
Stockholders' Deficit (Textual)
Common stock sold to several investors		5,000,000
Common stock at purchase price per share		$ 0.001
Proceeds of common stock		$ 5,000

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	43,136,540	38,136,540
Common stock, shares outstanding	43,136,540	38,136,540

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss

Income Taxes (Details 1) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred Tax Asset:
Net operating loss carryforward	$ 88,094	$ 79,801
Valuation allowance	(88,094)	(79,801)
Net deferred tax asset

Going Concern (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Going Concern (Textual)
Cash
Working capital deficit	279,640
Accumulated deficit	(523,872)	(464,007)
Stockholders' deficit	$ (279,640)	$ (245,147)	$ (215,249)

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2019	Feb. 28, 2020	Jun. 28, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	Tengjun Biotechnology Corp.
Entity Central Index Key	0001499785
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Filer Number	333-169397
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV
Entity Public Float			$ 22,670,675
Entity Common Stock, Shares Outstanding		43,216,580

Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 38,137	$ 162,815	$ (416,201)	$ (215,249)
Balance, shares at Dec. 31, 2017	38,136,540
Imputed interest		17,908		17,908
Net loss			(47,806)	(47,806)
Balance at Dec. 31, 2018	$ 38,137	180,723	(464,007)	(245,147)
Balance, shares at Dec. 31, 2018	38,136,540
Common stock issued for cash	$ 5,000			5,000
Common stock issued for cash,shares	5,000,000
Imputed interest		20,372		20,372
Net loss			(59,865)	(59,865)
Balance at Dec. 31, 2019	$ 43,137	$ 201,095	$ (523,872)	$ (279,640)
Balance, shares at Dec. 31, 2019	43,136,540

Income Taxes (Details) - USD ($)	12 Months Ended
Income Taxes (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income tax benefit at U.S. statutory rate	$ (12,571)	$ (10,039)
Non-deductible interest	4,278	3,761
Change in valuation allowance	8,293	6,278
Total provision for income tax

Summary of Significant Accounting Policies (Details Textual) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)
Cash equivalents
Prepaid expenses	$ 4,299	$ 4,000

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues
Operating Expenses:
Accounting fees	11,405	11,050
Other general and administrative	28,088	18,848
Total Operating Expenses	39,493	29,898
Loss from Operations	(39,493)	(29,898)
Other Expense:
Interest expense - related party	(20,372)	(17,908)
Total Other Expense	(20,372)	(17,908)
Net Loss	$ (59,865)	$ (47,806)
Net loss per common share, basic and diluted	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding:
Basic and diluted	39,862,567	38,136,540